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Abstract 
Growth hormone (GH), prolactin (PRL), placental lactogen (PL) and 
somatolactin (SL) belong to a family of pituitary hormones whose genes have been 
suggested to evolve through duplication of a common ancestral gene. PRL is a single 
chain polypeptide hormone that is synthesized in and secreted from the anterior 
pituitary of vertebrates. 
1« 
In vertebrates, PRL is involved in a variety of physiological processes including 
reproduction and lactation, growth, metabolism, behavior, immunoregulation, 
osmoregulation as well as effects on the ectoderm and skin. In teleosts, the most 
prominent role of PRL is the regulation of water and electrolyte homeostasis in � 
freshwater adaptation. 
Although the biochemical features of PRL have become increasingly clear, its 
three-dimensional structure, structure-function relationship in receptor binding and its 
biological functions in seawater and freshwater teleosts are still under investigation. In 
order to characterize fish PRL, large amounts of the pure hormone must be available. 
The aim of present study is to produce and purify large amounts of the recombinant 
hormone in Escherichia Coli {E. coli). 
Two PRL cDNA sequences encoding for the same polypeptide were isolated 
from a goldfish pituitary cDNA library. The goldfish PRL (gfPRL) cDNA was cloned 
ii 
into a prokaryotic expression vector (pRSETA) and was successfully expressed in E. 
coli. The recombinant gfPRL (rgfPRL) was purified by affinity chromatography and 
refolded for further investigations. The purified protein was then used to raise 
polyclonal antibodies against rgfPRL in the rabbit. This antibody can be used as a tool 
for detecting native PRL in the goldfish pituitary extract. Following alkaline extraction, 
highly purified PRL was isolated from the goldfish pituitaries by a two-step isolation 




Refolding of the rgfPRL after the renaturation processes was assessed in the 
receptor binding assay, using native gfPRL as a positive control. The results in receptor 
binding assay suggested that the rgfPRL has regained its structural and hormone- � 
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Chapter 1 Introduction 
1.1 Prolactin (PRL) 
1.1.1 General introduction 
Growth hormone (GH), prolactin (PRL), placental lactogen (PL) and 
somatolactin (SL) belong to a family of polypeptide hormones. . The findings of 
structural and functional similarities among these hormones from most vertebrates has 
led to the suggestion that they have evolved from a single ancestral gene through gene 
duplication followed by evolutionary divergence (Niall et al., 1971; Niall et al., 1973; 
Seo, 1985). � 
PRL exists in several molecular forms, some arising from posttranslational 
modifications (glycosylation, phosphorylation and deamidation) and others from 
genetically determined factors (alternative splicing and proteolytic cleavage). Such 
findings have led to the hypothesis that PRL is a prohormone, which is synthesized as a 
precursor molecule and then converted to different bioactive forms as it transverses its 
secretory pathway. Although recent evidence reported the existence of 
posttranslationally modified variants of PRL, most of them are simple proteins without 
any posttranslational modifications (Lewis, 1984; Lewis et al., 1984; Sinha, 1992). 
1 
1.1.2 Genomic organization of teleost PRL gene 
The genomic sequences of PRL genes have been determined for mammals and 
teleosts. Mammalian PRL appears to be encoded by a single gene (Miller and 
Eberhardt, 1983). In teleost, however, evidence for more than one PRL gene has 
recently been reported. Two cDNAs and two polypeptides for PRL have been 
characterized in carp (Yasuda et aL, 1987), eel (Suzuki et al., 1991) and tilapia 
(Yamagauchi et al., 1988). In tilapia, two distinctly different PRL molecules (tPRL177 
and tPRLigg) are equally expressed in the pituitary. These two PRL molecules share 
only 69% amino acids sequence homology and have different roles in the 
osmoregulatory processes. 
� 
Mammalian PRL genes contain five exons and four long introns, spanning a 
region of about 10 kb or longer (Tmong et al., 1984). In contrast to the mammalian 
PRL gene, according to the PRL genes isolated and characterized from common carp 
(Chen et al.，1991), chinook salmon (Xiong et al., 1992), channel catfish (Tang et al., 
1993) and tilapia (Swennen et al, 1992), fish PRL gene is a small gene of about 
2.5-3 kb, comprising also of five exons and four introns. 
In mammals, tissue-specific expression of the PRL gene has been shown to be 
regulated by a trans-acting factor encoding by the Pit-1 gene. Pit-1 is a POU domain 
transcription factor found in the anterior pituitary gland (Ono et al., 1994; Poncelet et 
al., 1997) that mediates pituitary-specific expression of PRL gene in mammals (Nelson 
2 
et aL, 1988; Lemaigre et al” 1989). Recently, Elsholtz et al, (1992) have found Pit-1 in 
salmonids. More recently, Poncelet et al. (1996) have shown that a Pit-l-like protein is 
present in the tilapia pituitary extracts. The results showed that the structure and 
function of Pit-1 are similar in teleosts and mammals, suggesting conserved molecular 
interactions between Pit-1 and its binding sites from fish through mammals. 
1.1.3 Conserved domains of fish PRL 
1» 
When comparing the amino ^cid sequences of PRLs from mammals and 
teleosts, some residues seem to be conserved among different species. These conserved 
residues are clustered in four distinct regions of the molecule. The significance of the 
conserved regions is not known, but it is likely that they are involved in maintaining the � 
conformation and stability of the molecule. Also, these domains may contain some 
determinants for specific binding to receptors and may be critical for the PRL specific 
activities. 
To date, the primary structures of only a small number of teleost PRLs have 
been elucidated. Currently, PRL sequences of rainbow trout (Mercier et al., 1989), 
tilapia (Yamaguchi et al., 1988), carp (Yasuda et al., 1987), chinook salmon (Song et 
al., 1986), chum salmon (Yasuda et al., 1986) and goldfish (Chan et al.，1996) are 
known. By means of amino acid (a.a.) sequence alignment, sequences of different 
teleost species can be compared by aligning the conserved half-cysteine residues and 
introducing several gaps to maximize sequence homology. From the sequence 
3 
alignment, it is found that teleostean PRLs are single-chain polypeptides of about 
21 kDa with two conserved disulfide bonds. From the sequence alignment, four highly 
conserved domains (ApRL, BpRL, CpRL and DpRL) have also been identified for the 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.1.4 Structure ofteleost PRL 
PRL is synthesized as a prehormone consisting of about 227 a.a. residues in 
most mammalian species. The mature hormone is derived from this precursor molecule 
by proteolytic cleavage of the 28-amino acid signal peptide from the amino terminus 
(Lingappa etal, 1977). 
Most of the members of the PRL family are simple proteins of about 190-200 
a.a. in length. They are all globular proteins with similar conformations. In most 
mammalian species, the hormone consists of 197-199 a.a. with three intramolecular 
disulfide bonds which exist between residues 4-11, 58-174 and 191-199 respectively. 
Teleostean PRLs, as compared with the mammalian PRLs, lack the amino-terminal � 
disulfide bridge (Fig. 1.2). The physiological significance of this N-terminal loop has 
not yet been determined, but it is believed that this loop may be responsible for 
stimulation of the mammary function (Sinha, 1995). The three-dimensional structures 
of mammalian and teleostean PRLs have not been experimentally determined yet, but 
since there is considerable sequence homology between PRL and GH, a three-
dimensional model of human PRL has been developed based upon the three-
dimensional structure of GH (Abdel-Meguid et al, 1987; De Vos et al, 1992; Goffin et 
al, 1995). Based on this model, it was proposed that PRL is composed of four a-helices 
organized in an antiparallel four-helical bundle, with the receptor-binding sites located 
on the same side of the folded protein. 
6 
Mammalian PRL Teleostean PRL 
r^ r ~ ^ 
0 '^( 
v^u.� 
Fig. 1.2 Schematic diagram of mammalian and teleostean PRL molecules. Mammalian 
and teleostean PRLs are displayed in two dimensions. They all possess a small 
loop of a.a. at the carboxyl terminus. A larger loop comprising about 70% of 
a.a. residues forms a second significant feature of these molecules. 
Mammalian PRL is distinctive from teleostean PRL in having a second small 
loop at the amino terminus (modified from Sinha, 1995). 
7 
1.1.5 Tissue sources of PRL 
PRL was originally found in the pituitary gland (Riddle et al., 1932; Frawley 
and Boockfor, 1991). In vertebrates, the lactotrophs of the anterior pituitary constitute 
the major site of PRL expression. In recent years, it was reported that PRL and PRL-
like molecules are present in a variety of tissues. However, the presence of PRL and 
PRL-like molecules does not necessarily mean that they are synthesized there. They 
may be involved in the modulation of the biological functions in these tissues. 
ff 
Besides the pituitary, PRL can also be synthesized in other tissues. In mammals, 
placenta (Handwerger et al., 1990) and mammary gland (Kurtz et al., 1993) are the 
richest source of PRL. It is also produced by uterine endometrium (Masler and Riddick, � 
1979)，myometrium (Walters et al” 1983) and fibroids (Nowak et al, 1993). Unlike 
mammals, production of PRL in fish is confined to the anterior pituitary (Nagahama et 
al., 1981; Naito et al., 1983; Garcia-Hemandez et al., 1996). Teleostean PRL is 
synthesized by the PRL-producing cells, which are segregated into a nearly 
homogeneous mass in the anterior-most portion of the pituitary, the rostral pars distalis 
(RPD). 
8 
1.2 Prolactin receptor (PRLR) 
1.2.1 Tissue distribution in teleosts 
PRL has been well known as the most versatile of all the pituitary hormones in 
its actions in vertebrates. Table 1.1 shows the distribution of PRL receptors (PRLR) in 
the mammalian and teleostean tissues (Loretz and Bem, 1982; Kelly et al., 1991; Sakai 
et al., 1996; Weng et al,, 1997). Such wide distribution of P ^ R has led to a 
suggestion that PRL exerts different actions in different species, ranging from the 
initiation and maintenance of lactation in mammals to the regulation of intracellular 
osmolarity in teleosts, many of which are characteristics to certain species. It should be 
noted that for some of these PRL binding sites, no direct association with a biological � 
response has been firmly established. 
9 
Mammalian tissues Teleostean tissues 
















Lymphatic and immune cells 
Brain 
Eye 
Table 1.1 Tissue distribution ofPRLR in mammals and teleosts (reconstituted from 
Loretz and Bem, 1982; Kelly et al., 1991; Sakai et al., 1996; Weng et al. 
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1.2.2 Receptor structure and multiple forms of PRLR 
PRLR belongs to the cytokine receptor family (Cosman et al., 1990). At 
present, most studies on PRLR have been focused on the liver and mammary gland. 
The structure of mature PRLR, deduced from the full-length cDNA from rat liver 
(Boutin et al., 1988)，is consisted of a ligand-binding extracellular domain (210 a.a.), a 
hydrophobic transmembrane domain (24 a.a.) and a cytoplasmic domain of varying 
sizes (Kelly et al,, 1993). In the functional studies of the relative contributions of 
various domains of PRLR to the mechanism of signal transduction pathway, it has been 
shown that two pairs of cysteines located near the N-terminal region may be involved in 
forming the ligand binding pockets for hormone binding. These cysteines, together 
with the conserved WSXWS motif (tryptophan, serine, any a.a., tryptophan, serine) � 
proximal to the transmembrane domain, are crucial to ligand binding and functional 
integrity ofPRLR (Rozakis-Adcock and Kelly, 1991; Rozakis-Adcock and Kelly, 1992) 
(Fig. 1.3). 
Up till present, several forms of PRLR have been characterized (Fig. 1.4). The 
short form is found in the mouse liver (Davis and Linzer, 1989) and rat liver (Boutin et 
al.’ 1988). The long form is found in human hepatoma cells (Boutin et al,, 1989) and 
rat ovary (Zhang et aL, 1990). The PRLR of intermediate size is found in rat Nb2 
lymphoma cells (Ali et al., 1992). In teleosts, there are relatively few studies on the 
PRLR structure. To date, cDNA coding for the PRLR was identified only in the livers 




Asn_ — Cys 
—Cys 
Asn_ - Cys 
Asn 一 ^ Extracellular domain 
‘ — C y s 
WSXWS motif > ^ m ^ B 
^ ^ ^ ^ g ^ Transmembrane domain 
^ ^ ^ ^ < Cytoplasmic domain 
I -
Fig. 1.3 Schematic diagram of the PRLR. Three potential N-linked glycosylation sites 
(Asn) are present. There are five extracellular cysteines (Cys), the first four 
are found near the N-terminal region, with the fifth one near the 
transmembrane domain. The WSXWS motif is indicated as a thick line and is 
located proximal to the transmembrane domain (modified from Kelly et al., 
1991). 
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„ M 600 a.a. 
Rat 606 a.a. 
Long-form Goldfish 
PRLR Tilapia Long-form 
Long-form PRLR 
PRLR 
Fig. 1.4 Schematic diagram of different forms of PRLR. Three potential N-linked 
glycosylation sites (N) and five extracellular cysteines (C) are located in the 
extracellular region. The WSXWS motif is indicated as a thick line and is 
located proximal to the transmembrane domain. The length of the mature 
hormone is indicated at the bottom of each receptor. 
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Only the long form receptor is found in teleosts. These three forms of PRLR have 
similar extracellular domains and transmembrane regions. Their major difference lies 
in the length of cytoplasmic region. 
Multiple forms of PRLR can be found within certain species. The structure of 
PRLR in the rat appears to be more complex than that of the human or rabbit, in which 
only a singe long form has been found. In rats, three forms of the PRLR have been 
identified: a short form in the rat liver; a long form in the rat ovary ^nd an intermediate 
form in the Nb2 lymphoma cell. Specific mRNAs encoding the three classes of PRLR 
have been detected. As deduced from the oligonucleotide sequences of three cDNAs, it 
has been suggested that the three transcripts may result from alternative splicing of a 
single gene (Shirota et al” 1990; Ali et al” 1991; Clarke and Linzer, 1993) � 
1.2.3 Possible action mechanisms of PRL 
To elicit biological responses on target cells, the initial step of the action 
mechanism is the binding of a hormone to its cell surface receptor. Currently, most 
studies on the PRLR have focused on the plasma membrane receptor. However, the 
majority of PRLR is located in the intracellular membranes such as endosomes, Golgi 
fractions and lysosomal structures (Djiane et al, 1981; Bergeron et al., 1986). This 
suggests a rapid turnover of PRLR in cells. This finding may support the hypothesis 
that after synthesis and targeting to the plasma membrane, binding of hormone will 
result in the internalization of the receptor. After targeting the hormone into the 
14 
intracellular side, PRLR is further internalized and degraded in the lysosomes (Djiane et 
al., 1982). Besides the plasma and intracellular membranes, PRLRs are found in the 
cytosol of liver, mammary gland and kidney cells (Ymer et al., 1987; Herington et al” 
1988). These soluble receptors exhibit a different binding affmity compared with that 
of the membrane receptors. It is suggested that these cytosolic PRLR may be involved 
in mediating the responses of intracellular PRL within the target cells. 
The events that occur after the binding of PRL to its cell sij^ rface receptor have 
been the subject of intense studies. It has been suggested that secondary messenger 
mechanisms may probably be involved. Because of the wide range ofbiological actions 
associated with PRL in different species and the existence of various forms of PRLR, 
there is little doubt that more than one action mechanism may be involved and several � 
kinds of secondary messengers may take part in the action mechanism. 
2+ 
Ca mobilization is the central event in many signal transduction pathways. 
Binding of PRL to its receptor evokes an increase in the concentration of cytosolic free 
Ca2+, which results from both the influx of extracellular Ca:+ through Ca�+ channels in 
the plasma membrane, and the release of sequestered Ca^^ from intracellular stores 
(Buckley et al” 1986; Lachowicz et al., 1997). Ca^ + serves as a second messenger to 
trigger intracellular responses by inducing a rapid activation of various Ca^^-dependent 
protein enzymes, such as protein kinase C (PKC) (Pasqualini et al, 1994; Chuang et al., 
1998), tyrosine kinases (Rui et al., 1992; Dausanter-Fourt et al., 1994; Montgomery et 
al., 1998) and c-src kinase (Berlanga et al., 1995). 
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The cyclic nucleotides, cyclic adenosine-3', 5'-monophosphate (cAMP) and 
cyclic guanosine 3，，5'-monophosphate (cGMP) are the second important class of 
secondary messengers in the PRL-induced action mechanisms (Johnston and Wigham, 
1988; Larsen, 1992; Gonzalez and Aguilar, 1999; Kau et al., 1999). cAMP stimulates 
the activity of cAMP-dependent protein kinase, which in tum phosphorylates and 
activates the enzymes required for glycolysis or gluconeogenesis and the mobilization 
of glycogen and fatty acids. Most of the actions of cGMP are believed to be mediated 
through cGMP-dependent protein kinase. The message carried ,by cGMP leads to 
change in ion-transport and water retention in kidney and intestine. 
• 2+ 
Besides Ca and cyclic nucleotides, diacylglycerol, which is produced in the 
hormone-sensitive phosphatidylinositol system, is a potential intracellular secondary � 
messengers for the PRL-induced action mechanisms (Martin and Kowalchyk, 1984; 
Laverriere et al., 1988; Johnson et al., 1990). It acts as a messenger to activate the 
actions ofPKC and the thyrotropin-releasing hormone. 
The influence or co-operation of one secondary messenger on the level of 
another is typical of many signal transduction systems. This starts a cascade ofenzyme 
activities in cells that initiates the physiological responses of the target cells. 
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1.3 Control of PRL release 
Like other pituitary hormones, the adjustment of PRL secretion by the PRL cells 
in the anterior pituitary is under tight control. Two mechanisms of the regulation of 
PRL release have been proposed: hypothalamic control (Ball, 1981; Hamano et al； 
1996; Power et al., 1996; Sukumar et al., 1997) and regulation by blood factors acting 
directly on the PRL cells, in particular plasma osmolarity (Wendelaar Bonga et al., 
1985; Day and Hinkle, 1988). ,. 
A 
Inhibitory influences of PRL secretion 
In teleosts, PRL secretion is under a primary inhibitory hypothalamic control. � 
Dopamine (Ball, 1981; Duvilanski et aL, 1996), y-aminobutyric acid (GABA) 
一 
(Duvilanski et al.’ 1996), somatostatin and its analog, urotensin II (Grau et al., 1982; 
Power et al., 1996) are effective PRL-inhibitory factors (PIF) released from the 
hypothalamus. They act on the PRL cells in the anterior pituitary and the response of 
the RPD to PIF in vitro is dose-related. 
Besides hypothalamic control, an increase in ion concentration in the ambient 
environment during the transfer of euryhaline fish leads to a marked decrease of PRL 
cell activity (Wendelaar Bonga et aL’ 1985). 
17 
Stimulatory influences of PRL secretion 
Secretion of PRL is mainly under an inhibitory control of the hypothalamus. 
Increase in PRL secretion during various physiological states appears to be mediated by 
both inhibition of secretion of the inhibitory hypothalamic hormones and by the release 
of the stimulatory hormones. Thyrotropin-releasing hormone (TRH) (Hamano et al” 
1996), vasoactive intestine polypeptide (VIP) (Balsa et al., 1996) and serotonin (Seki 
and Kikuyama, 1982) stimulate PRL secretion. •‘ 
Besides, a transfer of euryhaline fish such as salmonid fishes from seawater to 
freshwater has a stimulatory effect on PRL release (Sakamoto et al., 1997). Osmolarity 
of blood plasma is a factor in mediating the effects of the osmolarity of water on PRL � 
secretion. When transferred to freshwater, the lower ambient osmolarity will cause a 
rapid fall in plasma osmolarity. The PRL cells become activated and directly respond 
to this sudden change by increasing the rate of PRL release, subsequently raising the 
plasma osmolarity to the normal level. 
18 
1.4 Biological functions of PRL in vertebrates 
On the basis of the wide distribution of PRLR, numerous biological functions 
have been reported. As a result of the growing interest in the functions of PRL, it is 
possible to catalogue over one hundred distinct and diverse actions of PRL (Clarke and 
Bem, 1980). Some of these actions are more prevailing in certain species while less 
important in others. These actions ofPRL can be grouped into seven major categories: 
It 
1. Reproduction 产 
2. Osmoregulation 
3. Growth and development 
4. Metabolism � 
5. Behaviour 
6. Immunoregulation 
7. Effects on skin and ectoderm 
1.4.1 Biological effects on teleosts 
Among teleosts, osmoregulation in freshwater adaptation is the most prominent 
action in euryhaline and freshwater teleosts (Pmnet et al.’ 1985; Prunet et al., 1989; 
Sakamoto et al., 1997). Besides, studies on other actions of PRL including 
reproduction, behaviour, metabolism, immunoregulation and effects on skin have 
received increasing attention. 
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1.4.1.1 Osmoregulatory roles 
The physical and chemical properties of the environment in which marine and 
freshwater teleosts live are totally different. Table. 1.2 shows the concentration of 
major solutes in seawater, freshwater as well as in the plasma of some aquatic species 
(Livingstone, 1963; Potts and Parry, 1964; Bentley, 1971; Steinhom et al., 1979). 
Seawater contains about 3.5 % salt (1 L seawater contains 35 g salts) and the major 
solutes are Na+ and C1", with calcium, potassium and sulfate in substantial amounts. 
The osmotic concentration of seawater is about 1000 milliosmoles/L. Freshwater, on 
the contrary, has a minute amount of salts present and has an osmotic concentration of 
about 5 milliosmoles/L. 
� 
From Table 1.2，seawater teleosts are hypoosmotic to their living environment 
and are in constant danger of losing body water to the more concentrated seawater from 
their body surfaces. Freshwater teleosts, on the contrary, are hyperosmotic to their 
surrounding environment. Some aquatic animals can tolerate wide variations of salt 
contents in water. The euryhaline fishes, which move between seawater and freshwater, 
can adjust their blood osmotic concentrations during the transfer. For all these kinds of 




Habitat (mmoles/ litre of water) concentration 
N ? K ^ (mOsm litre ’ 
Seawater � 4 5 0 15 � 1 0 0 0 
Freshwater 0.39 004 ^ 5 
(river water) “ 
Toadfish Seawater 160 5 3 ^ 
Goldfish Freshwater 115 4 ^ 
Salmon Seawater 212 3 400 
Freshwater 181 2 340 � 
Eel Seawater 177 3 37] 
Freshwater 155 3 323 
Table 1.2 Concentration of major solutes (in millimoles per litre of water) in seawater, 
river water and in the plasma of some aquatic vertebrates (reconstituted from 
Livingstone, 1963; Potts and Parry, 1964; Bentley, 1971; Steinhom et al,, 
1979). 
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Currently, much of the studies focus on the contribution of hormones in 
euryhaline teleosts during the transfer (Iwata et al., 1982; Hasegawa et al., 1986; 
Hemdon et al., 1991; Sakamoto et al., 1997). To date, GH is known to contribute to 
seawater adaptation. PRL, on the other hand, plays an important role in the 
osmoregulation of freshwater teleosts (Hasegawa et al, 1986). 
As shown in Fig. 1.5, when chum salmons were transferred from seawater to 
freshwater, there was a significant increase in plasma GH level 6-.. 12 hours after the 
transfer. No change in plasma PRL level was observed. On the other hand, when the 
fish were transferred back from seawater to freshwater, the circulating PRL increased 
after 2-3 days. GH level decreased significantly 6 hours after the transfer and the low 

















































































































































































































































































































In teleosts, PRL has been shown to act on all osmoregulatory surfaces such as 
gills, kidney, urinary bladder, intestine and skin. 
The large surface area that the gills present to the environment together with 
their active interaction with the surroundings makes this organ the primary site for the 
exchange of water and electrolytes and consequently the principal target organ of PRL 
(Sakamoto et al, 1997; Weng et al., 1997). The gills of teleosts are thin, stratified 
epithelia, which contain four types of cells: mucous cells (MCX non-differentiated 
accessory cell (AC), the thin layer of surface pavement cells (PC) and the mitochondria-
rich chloride cells (CC) (Kamaky and Kinter, 1977; Marshall and Nishioka, 1980; 
Foskett et aL, 1981). 
% 
The CC (Fig. 1.6) are the main ion-transporting cells of the gills where salt 
secretion occurs. These cells are characterized as being rich in large, well-developed 
mitochondria in close association with a greatly amplified membraneous system. The 
membraneous system is continuous with the basolateral membrane, which is so 
elaborate that it fills nearly all the cell. In fact, much of the interior of the CC is 
extracellular space (Philpott, 1980). It was found that CC are responsible for C1" 
excretion in marine teleosts and for C1" absorption in freshwater teleosts. It should be 
noted that a passive Na+ movement is always coupled to active Cf transport (Foskett et 
aL, 1982; Day and Hinkle, 1988). 
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Fig. 1.6 Generalized diagram of filamental epithelium and chloride cell. Chloride cell 
is characterized by the presence of large and well-developed mitochondria. 
The greatly amplified membraneous system provides a larger surface for the 
exchange of ions across the gill filaments in the teleosts (modified from 
Wendelaar Bonga, 1997). 
25 
Na+-K+-ATPase is an ion-translocating enzyme present on the basolateral 
tubular membrane system of CC (Fig. 1.7) (Kamaky, 1986). In CC, Na+-K+-ATPase 
creates ionic and electrical gradients that are used for salt excretion in seawater, and 
possibly for ion uptake in freshwater. In seawater, the teleost gill has a higher level of 
Na+-K+-ATPase, associated with its high rate of outward Na+ pumping from the cell 
into the interstitial fluid and thereby contributing to salt excretion (Sakamoto et al., 
1997). In freshwater, the level of this enzyme is much lower. This reduces the efflux of 
Na+，so promoting freshwater tolerance (Flik et aL, 1994). .. 
fT 
Teleosts in freshwater take up calcium directly from the water via their gills to 
meet their needs for growth and homeostasis (Fig. 1.7) (Flik et al., 1985). Calcium 
influx is mediated by the Ca^^-ATPase located mainly in the plasma membrane of � 
ionocytes of the branchial epithelia and in the basolateral tubular membrane system of 
CC (Flik et al., 1985; Flik et al, 1989; McCormick et al” 1992). Plasma Ca?+ and Mg�+ 
levels antagonize each other. Calcium influx is usually accompanied by magnesium 
efflux. In case ofCa�+ homeostasis, C1' acts as a counterion to the movement ofcations. 
As a result, the total divalent cation content of the plasma is kept constant (Flik et al., 
1989). 
PRL promotes freshwater tolerance in which it increases branchial permeability 
to water and ions, resulting in net uptake ofNa+ and Ca?+ (Flik et al., 1986). In case of 
sodium transport, although PRL increases the density ofCC, their sizes become smaller 
26 
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Fig. 1.7 Schematic representation of gases and ions transport across the gill epithelium 
of freshwater (A) and seawater (B) teleosts. Active transport and co-transport 
are indicated by solid lines and diffusion by dashed lines. Pavement cell (PC), 
chloride cell (CC) and accessory cell (AC) are also indicated (modified from 
Marshall, 1995;Flik et al., 1996). 
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with a lower level ofNa^-K^-ATPase (Hemdon et al., 1991; Flik et cd., 1994). It seems 
that PRL causes a dedifferentiation of CC population, possibly by blocking the 
differentiation of new cells to replace those that have wom out. It results in the 
development of CC with a lower Na+-K+-ATPase content and as a result, efflux of 
sodium decreases. 
Besides stimulating calcium influx from the water, PRL enhances the calcium 
transport capacity of the gills by increasing the density ofhigh-affinity Ca^^-ATPase in 
plasma membrane of ionocytes, thus preventing the calcium efflux to water (Flik et aL, 
1985; Flik et al., 1989; Flik et al., 1994). 
Hydromineral regulation in teleost is the result of integrated transport activities � 
of all the osmoregulatory surfaces. Besides the gills, PRL also acts on the skin, 
intestine, kidney and urinary bladder. 
The skin presents another boundary for ionic exchanges and limitation of ion 
efflux by this surface is of great importance in freshwater teleosts. PRL increases the 
density of dermal mucocytes (Flik et al., 1994). PRL stimulation ofmucus secretion at 
various body sites reduces the skin permeability, enables the freshwater teleosts to 
maintain blood ion levels far more concentrated than the surrounding environment. 
Freshwater teleosts usually "drink" less than seawater teleosts to minimize the 
water influx as it would lower their blood plasma osmolarity. In case of intestine, PRL 
28 
probably acts by decreasing intestinal permeability to water and suppressing the 
intestinal chloride pump (Utida et al., 1976; Morley et al., 1981). 
In kidney, PRL acts by increasing the Na+-K+-ATPase level so as to decrease the 
Na+ concentration in urine. It also helps the renal system to maintain a high glomerular 
filtration rate along with active reabsorption of filtered ions (Wendelaar Bonga and 
Veenhuis, 1974; Wendelaar Bonga, 1976). In the urinary bladder, PRL promotes the 
rate ofreabsorption of filtered ions and decreases its permeability to water (Utida et al., 
1972; Doneen, 1976). As a result, a copious dilute urine will be produced to 
compensate for high permeability for the whole fish. 
1.4.1.2 Non-osmoregulatory roles � 
Parental behavior 
PRL has been suggested as a parental hormone in teleosts. In female tilapia, 
PRL promotes the brooding behavior of the post-yolksac larvae (Weber and Grau, 
1999). In some cichild fishes, PRL elicits the fanning behavior in males (Slijkhuis et 
fl/.，1984; De Ruiter et al” 1986). Fanning is an important aspect ofparental care which 
a stream of freshwater is propelled over the eggs by means of the pectoral fins. After 
fertilization, male sticklebacks spend increasingly more time fanning the egg. It results 
in refreshment ofthe water around the eggs and newly hatched young. 
29 
Effect on metabolism 
In the premature stage, the salmonid fish have to move back to the sea for 
growth and development. Seawater pre-adaptive development of salmonid fish 
(smoltification) involves enhanced catabolism of body reserves. Smoltification is 
associated with depletion of total body lipids and glycogen (Woo et al., 1978; Sheridan 
et al., 1983; Sheridan, 1985). In developing salmon, PRL stimulates lipid mobilization 
by enhancement of lipolysis in all the depots: liver, dark tissue..and mesenteric fat 
(Sheridan, 1986). 产 
Immunoregulation 
% 
The relationship between the neuroendocrine and the immune systems has been 
the subject ofintense studies. Immunoregulatory effects ofPRL on the immune system 
of fish have attracted increasing attention. Berczi and Nagy (1987) demonstrated the 
stimulatory effect of PRL on both primary and secondary lymphoid organs in rats. 
Bemton et al (1988) reported the stimulatory action of PRL in rat macrophages. In 
fish, there are relative fewer studies on the immunoregulatory action of PRL. Recently, 
it was demonstrated that PRL increased the phagocytic activities of macrophages by 
enhancing their production of superoxide anions (Sakai et al, 1996). 
30 
Effect on skin 
PRL regulates pigment migration in teleosts. In teleosts, melanophores, 
erythrophores and xanthophores are pigment cells that are present in their skin 
throughout the year. Melanophores are responsible for skin darkening and blanching 
reactions of the fish. Erythrophores and xanthophores are "brightly pigmented" cells. 
Dispersion ofthese two kinds of pigmented cells can produce yellowish ofreddish color 
of the skin. •‘ 
/r 
PRL induced skin darkening in cultured scale of tilapia by causing pigment 
aggregation of melanophores (Kitta et al., 1993). The effect was reversed after 
removal of PRL. The response of melanophores to PRL may help the fish to adapt to � 
the surrounding environment, thus escaping from their predators. In case of 
erythrophores and xanthophores, PRL caused pigment dispersion in the cultured scale 
of tilapia (Oshima et al., 1996). The effect was much enhanced with increasing 
concentrations of the hormone. The responsiveness ofthe "brightly pigmented" cells to 
PRL may be associated with the breeding season. 
31 
1.5 Aim of the present study 
Two full-length nucleotide sequences have been isolated from the goldfish 
pituitary cDNA library, namely PlA and P8A (Fig. 1.8) (Chan et al., 1996). The two 
cDNA clones share a common open reading frame and the predicted protein coding 
regions of these clones were found to encode for the same hormone precursor, which 
consists o f a 2 3 a.a. signal peptide and a 187 a.a. mature hormone. Goldfish PRL shares 
high nucleotide and a.a. sequence homologies with other teleost PRLs. A comparison 
ofsequence identities among the teleost PRLs is shown in Table 1.3. 
Using goldfish as a model system, the aim of the present study was to subclone 
the gfPRL cDNA, P8A into an appropriate expression vector and to produce large � 
amounts ofthe highly purified active recombinant gfPRL in E. coli, In this thesis, the 
production of high titre polyclonal antibodies in rabbits is described. The isolation of 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Amino acid sequence Nucleotide sequence 
Sequence identities 
(mature hormone portion) (mature hormone portion) 
Goldfish PRL (P8A) 100% [00% 
Common carp PRL 97 % 95 o/o 
I* 
Bighead carp PRL 产 97 % 93。/。 
Silver carp PRL 96 % 93。/。 
Chinook salmon PRL 81 % 73 0/0 
Chum salmon PRL 81 % 730/� � 
Rainbow trout PRL 81 % 730/� 
Eel PRL 80% ‘ 71 % 
TilapiaPRLi88 76 % 71 % 
Tilapia PRL177 66 % 66 % 
Table 1.3 Comparison of amino acid sequence and nucleotide sequence identities of 
gfPRL with other teleost PRLs (modified from Chan et al., 1996) 
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Chapter 2 Recombinant goldfish {Carassius auratus) prolactin: 
subcloning, expression, purification and refolding ofthe 
protein in vitro 
2.1 Introduction 
Two full-length gfPRL cDNA sequences, namely PlA and P8, have been 
1» 
isolated from a goldfish pituitary cDNAlibrary (Fig. 1.8) (Chan et al., 1996). To study 
the gfPRL in detail, large amount of the purified protein is required. Isolation of the 
hormone from fish pituitaries (Andersen et al” 1989; Dores et al., 1993) yielded only 
limited amounts of the hormone. To produce large amount ofPRL, the cloned gfPRL � 
cDNA P8A, was expressed using a bacterial expression system. 
The PRL protein coding sequence of gfPRL gene, P8A was subcloned into a 
prokaryotic expression vector, pRSETA using two specific designed primers. The 
gfPRL was expressed as a fusion protein containing an N-terminal polyhistidine 
sequence, which facilitated its purification on a Ni^^-chelating affinity column. An 
enterokinase cleavage site was encoded between the polyhistidine sequence and the 
gfPRL cDNA to allow removal of the polyhistidine residues from the gfPRL after the 
purification of protein (Fig. 2.1). In pRSETA, the gfPRL cDNA was inserted 
downstream ofthe T7 promotor. To drive high-level expression ofthe protein, T7RNA 
polymerase must be supplied. 
35 
^ ^ ^ ^ ^ 
^ ^ ^ “ ^ A m p r 
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^ ^ ^ ^ � 
一 T7Promotor - “ H i s gfPRL cDNA 一 T — 
ECS ‘ 
Fig. 2.1 Goldfish PRL in prokaryotic expression vector. The pRSETA vector has the 
Coffil origin ofreplication, ampicillin resistant element, an expression cassette 
including the T7 promotor, polyhistidine metal binding domain, enterokinase 
cleavage site (ECS) as well as a transcription terminator. The target gene is 
cloned under the control of strong T7 promotor. The insert will be expressed 
by providing a source ofT7 RNA polymerase in the host cells. 
36 
Production of rgfPRL was carried out in E. coli. In this case, a host E. coli 
strain BL21(DE3)pLysS was chosen since it carries a chromosomal gene copy ofT7 
RNA polymerase which is under the control of a /^ zcUV5 promotor. The T7 RNA 
polymerase produced after the induction with IPTG would in tum drive the expression 
ofrgfPRL. 
Recombinant protein expressed in E. coli usually accumulates as inclusion 
bodies: insoluble aggregates of misfolded protein. Purification ofthe protein from these 
insoluble aggregates requires denaturing conditions. The insoluble gfPRL was 
solubilized in 6 M guanidine hydrochloride before loading onto the immobilized Ni?+ 
chelating affinity column. After washing the column under appropriate conditions 
several times to remove the background contaminants, the target protein was eluted. � 
A protein purified under denaturing condition is misfolded and generally lacks 
biological activities. To regain its biological activities, the soluble protein must be 
refolded and oxidized to generate native disulfide bonds. During refolding, the 
tendency ofthe partially folded intermediates to reaggregate is a major complication in 
the processing of the denatured protein. To minimize the association of the partially 
folded intermediates, the refolding steps must be carried out using very dilute solutions, 
often containing less than 1 mg protein / ml (Jones et al, 1995). After the refolding 
process, the yield of the refolded protein can be determined by the sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Weber and Osbom, 1969) 
under reducing and non-reducing conditions. 
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2.2 Materials 
0.5 M EDTA 
Na2EDTA • 2H2O i8.6g 
ddH2O to 70 ml 
Adjust to pH 8.0. Bring the volume to 100 ml and sterilize by autoclaving at 121 °C for 
20 min. 
11 
6X loading buffer for agarose gel electrophoresis 
Bromophenol blue 0.25 % w/v 
Xylene cyanol FF 0.25 % w/v 
Sucrosc 40 % w/v � 
50X TAE buffer 
Tris base 242 g 
Glacial acetic acid 57 i ml 
0.5 M EDTA, pH 8.0 100 ml 
Add ddH2O to 1 litre. 
CG medium 
CIRCLEGROW (BIO 101，Inc., USA) 48 g 
Add ddH2O to 1 litre, sterilize the mixture by autoclaving at 121 °C for 20 min. 
38 
CGA agar plate 
CIRCLEGROW (BIO 101，Inc., USA) 48 g 
Agar 1.5%w/v 
Ampicillin (100 mg/ml) 1 ml 
Add ddH2O to 1 litre, sterilize the mixture by autoclaving at 121 °C for 20 min. After 
cooling the CG agar to about 50 "C, ampicillin (100 ^ig/ml) is added and mixed well 
before pouring the plate. 
1» 
SOB medium " 
SOB (BI0101,Inc., USA) 31 g 
Add ddH2O to 1 litre, sterilize the mixture by autoclaving at 121 °C for 20 min. 
% 
SOBAC agar plate 
SOB (BI0101,Inc.,USA) 31 g 
Agar 1.5%w/v 
Ampicillin (100 mg/ml) 1 ml 
Chloramphenical (34 mg/ml) 1 ml 
Add ddH2O to 1 litre, sterilize the mixture by autoclaving at 121 °C for 20 min. After 
cooling the SOB agar to about 50�C，ampicillin (100 ng/ml) and chloramphenical 
(34 ^g/ml) are added and mixed well before pouring the plate. 
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10 % (w/v) SDS 
Sodium dodecyl sulfate 50 g 
Add ddH2O to 500 ml and warm the mixture until SDS has dissolved. 
Isopropylthio-P-D-galactopyranoside (IPTG) 
IPTG 100mM 
Dissolve in 10 ml of ddH2O, filter with a 0.2 i^m disposable syringe filter and store the 
aliquots at -20 °C. “ 
产 
5-bromo-4-chIoro-3-indolyl-p-D-galactoside (X-gal) 
X-gal 50 mM 
Dissolve in 10 ml of ddH2O. Filter the solution with a 0.2 i^m disposable syringe filter. 
Aliquot the filtrate into tinfoil-wrapped vials and store them at - 2 0 X -
Solution I 
1 M Tris-HCl, pH 8.0 5 ml 
0.5 M EDTA, pH. 8.0 4 ml 
20 % Glucose 9 ml 
Add ddH2O to 200 ml. 
4 0 
Solution II 
10%SDS 10 ml 
lMNaOH 20 ml 
Add ddH2O to 100 ml. 
Solution III 
Potassium acetate 3 j^ 
Adjust to pH 4.8 with glacial acetic acid. .. 
r 
AcryIamide stock (30:0.8) 
Acrylamide 39 g 
Bis-acrylamide 0.8 g � 
Dissolve in 100 ml ofddH2O. 
Upper buffer (for SDS-PAGE) 
Tris base 0.5 M 
Dissolve in 100 ml of ddH2O. Adjust to pH 8.8. 
Lower buffer (for SDS-PAGE) 
Trisbase 1.5M 
Dissolve in 100 ml ofddH2O. Adjust to pH 6.8. 
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5 o/o stacking gel (for SDS-PAGE) 
Upperbuffer 0.75 ml 
Acrylamide stock 0.5 ml 
lOo/oSDS 0.03 ml 
lOo/oAPS 0.04 ml 
TEMED 3 ^1 
ddH2O 1.65 ml 
1« 
15 % separating gel (for SDS-PAGE) 
Lowerbuffer 1.25 ml 
Acrylamide stock 2.5 ml 
lOo/oSDS 0.025 ml � 
lOo/oAPS 0.075 ml 
TEMED 1.25 i^l 
ddH2O 1.15 ml 
SDS-PAGE running buffer 
Tris base 5 g 
Glycine 28.8 g 
SDS 5 g 
Dissolve in 1 litre ofddH2O. 
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SDS sample buffer (denaturing) 
Upper buffer j ml 
10%SDS 1ml 
Glycerol 1 ml 
p-mercaptoethanol 0.1 ml 
0.05 % bromophenol blue 0.2 ml 
ddH2O 4.7 ml 
1« 
Coomassie blue staining buffer (for SDS-PAGE) 
Coomassie brilliant blue R-250 0.5 g 
Cupric acetate o.5 g 
Glacial acetic acid 50 ml 
Isopropanol 125 ml 
ddH2O to 500 ml 
Destaining solution (for SDS-PAGE) 
Glacial acetic acid 10 % w/v 




Tris base 200 mM 
NaCl 8%w/v 
ddH2O to 800 ml 
Adjust to pH 8.0. Add ddH2O to 1 litre. 
Column recharging solution (for purification) 
NiCl2 hexahydrate 0.5 g -
Dissolve in 100 ml of ddH2O. -
10X stock solution A (for purification) 
NaH2PO4 200 mM 
NaCl 5 M 
Dissolve in 1 litre ofddH2O. 
10X stock solution B (for purification) 
Na2HPO4 200 mM 
NaCl 5 M 
Dissolve in 1 litre ofddH2O. 
4 4 
Guanidinium lysis buffer (for purification) 
10X stock solution A 0.58 ml 
10X stock solution B 9.42 ml 
Guanidine hydrochloride 6 M 
ddH2O to 90 ml 
Adjust to pH 7.8. Bring the volume to 100 ml and filter sterilize the buffer with a 
0.45 i^m filter. 
II 
Denaturing wash buffer 6.0 (for purification) 
10X stock solution A 7.38 ml 
10X stock solution B 2.62 ml 
Guanidine hydrochloride 6 M � 
dd&C) to 90 ml 
Adjust to pH 6.0. Bring the volume to 100 ml and filter sterilize the buffer with a 
0.45 i^m filter. 
Denaturing wash buffer 5.3 (for purification) 
1 OX stock solution A 9 \ 7 ml 
1 OX stock solution B 0.83 ml 
Guanidine hydrochloride 6 M 
4犯20 to 90 ml 
Adjust to pH 5.3. Bring the volume to 100 ml and filter sterilize the buffer with a 
0.45 i^m filter. 
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* 
Denaturing eIution buffer (for purification) 
1 OX stock solution A 1 o ml 
Guanidine hydrochloride 6 M 
ddH2O to 90 ml 
Adjust to pH 4.0. Bring the volume to 100 ml and filter sterilize the buffer with a 
0.45 ^m filter. 
Transfer buffer (for Western blotting) 
Tris base . 25 mM 
Glycine 192 mM 
Methanol 20 % w/v 
Adjust to pH8.3. � 
TTBS (for Western blotting) “ 
Tris base 20 mM 
NaCl 0.8 % w/v 
Tween 20 0.1 %w/v 
Adjust to pH 7.5. 
Blocking buffer (for Western blotting) 
5 0/0 skim milk powder in TTBS. 
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Developing solution (for Western blotting) 
Tris-HCl, pH 9.0 0.1 M 
MgCl2 5 mM 
BCIP 0.15mg/ml 
仰 1 0.3 mg/ml 
The solution should be freshly prepared. 
Renaturing solution ,. 
P-mercaptoethanol - 5 mM 
EDTA 2 mM 
GSH 5 mM 
GSSG 0.5 mM � 




2.3.1 Subcloning ofthe gfPRL cDNA 
2.3.1.1 PCR cloning ofgfPRL cDNA 
The two different cDNA clones, PlA and P8A, isolated from goldfish pituitary 
library, were found to encode the same protein precursor comprismg 23 a.a. of signal 
peptide and 187 a.a. of mature hormone (Chan et al” 1996). Using the P8A as a 
template, the cDNA for the mature hormone was amplified by PCR using gene specific 
primers, which primed to the 5’ end and 3’ end of the mature protein coding region of 
the gfPRL cDNA, creating a BamHl site at the 5 ’ end and an EcoRl site at the 3，end. � 
BamUl ^ 
CCPRL-5: 5，GTG GAT CCG TCG GTC TGA ATG ATT TAC 3’ 
Ecom 
CCPRL-3: 5，GTG AAT TCC TAA CAC ATC TCA GGT CTC 3’ 
For the 50|al PCR mixture, 1 p,l of P8A cDNA clone was used as a template. 
Then, IX pfu reaction buffer, 1 mM dNTP mix, 50 pmoles ofprimer CCPRL-5 and 50 
pmoles of primer CCPRL-3 were added. The PCR was carried out in a PTC-100 
Programmable Thermal Controller (MJ Research, USA) with the following programme: 
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Initial denaturation: 
94 °C, 1 min. 
1 unit of pfu polymerase was added to the reaction mixture. Then, mineral oil 
was laid on the top of the reaction mixture to prevent evaporation during PCR. 
Repeated for 35 cycles: 
55 °C, 45 sec. (Annealing of primers) 
ii 
72 °C, 1 min. (Primer extension) 
94�C，1 min. (Denaturation) 
Final extension: 
72 OQ 5 min. 
% 
After the reaction, the PCR products were analyzed on a 1 % (w/v) agarose gel 
in IX TAE running buffer at a constant voltage of 100V. A band of about 600 bp was 
excised from the gel and was subjected to gene-clean using the Sephaglas™ BrandPrep 
Kit (Pharmacia). 
The gene-cleaned band and the pUC 18 plasmid vector were digested with 
BamRl and EcoRl at 37 °C for 2 hr. After the digestion, the DNA fragment was ligated 
to the linearized vector. For a 20 i^l ligation reaction, 10 i^l of linearized vector, 5 i^l 
DNA insert, IX One Phor All buffer (Pharmacia), 0.2 mM dATP and 1 unit ofT4 ligase 
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(Pharmacia) were mixed and incubated at 16 °C ovemight for the ligation reaction to go 
to completion. 
After the ovemight incubation, the ligated plasmids (pUC 18/gfPRL) were 
transformed into the DH5a competent cells. For the transformation, 10 ^1 of the 
ligation products were added into 100 t^l ofDH5a competent cells and the mixture was 
kept on ice for 30 min. Then, the mixture was heat-shocked for 90 sec. After chilling 
on ice for 2 min., 1 ml of pre-warmed CG medium was added^to the cells. The cells 
were allowed to recover by incubating them at 37 °C for 1 hr. Finally, the cells were 
spreaded over a CGA agar plate together with 30 i^l IPTG and 30 i^l X-gal and the plate 
was incubated at 37 °C ovemight. 
% 
After ovemight incubation, transformants containing pUC 18/gfPRL were 
selected as they appeared as white colonies on the plate. The white colonies were 
picked and inoculated into 3 ml of CG medium containing ampicillin (100 ^g/ml). The 
cells were incubated in an orbital shaker at 37 °C ovemight. To confirm the size and 
sequence of DNA insert in the plasmid, the plasmid was isolated by a plasmid 
minipreparation procedure, which was a slight modification of the one presented in 
Sambrook et al. (1989). One ml of bacterial cell culture was centrifuged to collect the 
cell pellet. The cells were resuspended in 100 ^1 of Solution I. After that, Solution II 
and Solution III were added. After centrifiigation, the clear supernatant was transferred 
to a clean tube and was precipitated with 100 % ethanol at -20 °C for at least 20 min. 
Then，the mixture was centrifuged to pellet the DNA. The DNA pellet was washed 
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with 70 % ethanol to remove the remaining contaminants. After spinning, the 70 % 
ethanol was poured off and the pellet was allowed to air-dry for about 10 min. Finally, 
the pellet was resuspended in 25 ^1 of dd H2O. The size of insert in the plasmid was 
checked by restriction enzyme digestion. From the results, positive clones were 
identified and purified by QIAprep Spin Miniprep Kit (Qiagen) for DNA sequencing. 
2.3.1.2 DNA sequencing ofthe subcloned fragment 
t* 
r 
DNA sequencing of the positive clones was carried out in the ABI PRISM™ 
310 Genetic Analyser (Perkin-Elmer). M13/pUC forward and reverse sequencing 
primers (Gibco BRL) were used to amplify the cloned fragment in the pUC vectors for � 
cycle sequencing. 
M13/pUC forward primer: 5，CCC AGT CAC GAC GTT GTA AAA CG 3’ 
M13/pUC reverse primer: 5' AGC GGA TAA CAA TTT CAC ACA GG 3’ 
A fluorescence-based cycle sequencing reaction was done using the ABI 
PRISM™ dRhodamine Terminator Cycle Sequencing Ready Reaction Kit (Perkin-
Elmer) except with some modifications. Five hundred nanograms (4.4 |al) of the 
plasmid (pUC18/gfPRL) was used as template for the 10 ^1 PCR reaction. For each 
reaction, 1.6 i^l of the M13/pUC forward/reverse primer and 4 i^l of Terminator Ready 
Reaction Mix were added. The PCR was carried out with the following programme for 
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25 cycles: 96�C，10 sec; 50�C, 5 sec and 60�C，4 min. At the end ofthe PCR, 1 ^1 of 
calf intestine alkaline phosphatase (Gibco BRL) was added and the tubes were 
incubated at 37 °C for 30 min. Excess dye terminators were removed by adding 3 ^1 of 
3 M sodium acetate, pH 4.6 and 50 i^l of 95 % EtOH to the mixture. The tubes were 
left in -20°C freezer for 2 hr. to precipitate the extension products. The precipitated 
DNA was then centrifuged, washed with 70 % EtOH and dried under the vaccum for 5 
min. Finally, the pellet was resuspended with 12 i^l Template Suppression Reagent 
(Perkin-Elmer), heated at 99 °C for 2 min. and chilled on ice before loading into the gel. 
r 
2.3.1.3 Subcloning of the gfPRL cDNA fragment into the expression vector 
After sequencing, pUC 18 of the correct insert was digested with restriction � 
enzymes, BamHI and EcoRl to release the gfPRL DNA fragment. At the same time, the 
prokaryotic expression vector, pRSETA (Invitrogen) was linearized using the same set 
of enzymes. After digestion, the products were fractionated by 1.5 % (w/v) agarose gel 
electrophoresis. The gfPRL DNA and the linearized pRSETA were excised and 
purified from the agarose gel by gene-clean using the Sephaglas™ BrandPrep Kit 
(Pharmacia). 
Ligation was carried out as mentioned in Section 2.3.1.1. After incubating the 
ligation mixture at 16 °C overnight, the ligated plasmid was transformed into DH5a 
competent cells. Again, the plasmids were isolated for restriction enzyme cutting. 
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Positive clones were identified and purified using the QIAprep Spin Miniprep Kit 
(Qiagen) for transformation and expression in E. coli strain BL 21 (DE3) pLysS. 
2.3.2 Expression and purification of rgfPRL 
2.3.2.1 Transformation ofpRSETA/giPRL into BL21(DE3)pLysS cells 
The plasmid pRSETA7gfPRL constructed previously was transformed into the 
II 
BL21(DE3)pLysS competent cells. ,The competent cells were first thawed on ice for 
10 min. Then 2 i^l of plasmid DNA (~ 1 ng) was added into the competent cells and the 
reaction mix was kept on ice for 30 min. The mixture was heat-shocked for exactly 90 
sec. After chilling on ice for further 2 min., 1 ml of pre-warmed SOB medium was � 
added to the cells. The cells were allowed to recover by incubating them at 37 °C for 1 
hr. Finally, the cells were spreaded over the SOBAC agar plates and they were 
incubated at 37 °C overnight. 
2.3.2.2 Prokaryotic expression of rgfPRL 
Before carrying out the large-scale expression of the rgfPRL, a pilot expression 
ofrgfPRL was done to check the level of expression in each clone. A single colony was 
picked from the SOBAC agar plate and was inoculated into 3 ml of SOB medium 
containing ampicillin (100 ^ig/ml) and chloramphenicol (34 ^ig/ml). The bacterial cells 
were grown at 37 °C overnight in an orbital shaker shaking at 280 rpm. On the 
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following day, expression was carried out by inoculating 20 ^1 of ovemight culture into 
3 ml of SOB medium containing ampicillin (50 ^g/ml) and chloramphenicol (17 
Mg/ml). The tubes were shaken at 280 rpm in a 37 °C orbital shaker until the OD260 
reached 0.4 - 0.5. IPTG was added to each tube to a final concentration of 1 mM to 
induce expression of the recombinant protein. Also, an uninduced control cell culture 
(without the addition of IPTG) was grown to show the basal level protein expression in 
the absence ofIPTG. The cells were allowed to grow for 4 hr after the IPTG induction. 
After the incubation, the expression level was monitored by,.SDS-PAGE (Laemmli, 
1970). The cells harvested from the cultures were lysed in 2 x sample buffer and the 
level of protein expression was analyzed by 15 % SDS-PAGE under reducing 
conditions. The discontinuing gel consisted of a 5 % stacking gel and a 15 % separating 
gel. The gel was run at a constant current of 30 mA. After the electrophoresis, the gel � 
was stained with the Coomassie blue staining buffer for 20 min. To remove the 
background color, the gel was then destained with the destaining solution for about 1 hr. 
From the result of SDS-PAGE analysis of the pilot expression, clone 2 was 
chosen for the time-course study and large-scale expression. A time-course study was 
carried out by collecting samples at different time levels after the induction of IPTG. 
For large-scale expression, an ovemight culture of clone 2 ( � 3 ml) was diluted into 250 
ml SOB medium, in the presence of ampicillin (50 ^g/ml) and chloramphenicol (17 
|ig/ml). The culture was incubated with shaking at 3 7 � C until the OD260 reached 0.4 -
0.5. A sample for the uninduced control was removed for titering. Expression of 
rgfPRL was induced by addition of IPTG to 1 mM. The culture was grown at 37 °C in 
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an orbital shaker for 8 hr. After the incubation, the cells were collected by 
centrifugation at 6000 x g for 20 min. Production of rgfPRL was monitored by 15 % 
SDS-PAGE analysis. 
2.3.2.3 Affinity purification ofrgfPRL 
While many proteins remain soluble during expression, many others will form 
insoluble aggregates. Before making a decision of whether to purify the tagged protein 
under native or denaturing conditions, it is important to determine whether the protein is 
in soluble form, or exists as inclusion bodies. 
In order to release the recombinant protein from E. coli, the cells harvested � 
before were resuspended in 50 ml of IX TBS. The resupending cells were first 
disrupted by 3 x freeze-thaw cycles. Then, extracts were sonicated with a microtip for 5 
min (30 sec sonication - 30 sec rest alternate cycles) at a high output setting to release 
more trapped proteins and to shear the DNA and RNA. The soluble and insoluble 
protein extracts from the E. coli were separated by centrifugation at 10,000 x g for 20 
min. Aliquots from the two fractions were analysed on 15 % SDS-PAGE gel. From the 
results，rgfPRL was mainly present in the insoluble fraction and so, purification was 
allowed to proceed under the denaturing conditions. 
Protein expressed from pRSETA vector contained a 6 x His affinity tag in the 
N-terminal, which facilitated its purification on the ProBond™ resin (Invitrogen). 
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Insoluble aggregates were washed briefly with IX TBS twice to remove adhering 
impurities. Then，the pellet (~ 2 g) was dissolved in 20 ml of guanidinium lysis buffer, 
pH 7.8. The solution was slowly rocked for 1 hr. at room temperature to assure 
thorough protein solubilization. Afterwards, the sample was centrifuged at 10,000 x g 
to remove insoluble cell debris. The clear sheared lysate was stored at 4 °C before 
loading onto the affinity column. 
Ten milliliters of resuspended ProBond™ resin were put into the column with 
the snapped-off cap. Storage solution was allowed to drain off. The column was 
washed with 2 column volumes of ddH2O. Then, it was equilibrated with 3 column 
volumes ofguanidinium lysis buffer, pH 7.8. After the equilibration, the sheared lysate 
prepared before was loaded on to the column. The affinity column was slowly rocked � 
for 1 hr. to keep the resin resuspended and to allow full binding of the His-tagged 
protein to the resin. The resin was settled by gravity and the flowthrough was collected. 
Then，the column was washed sequentially with 4 column volumes ofguanidinium lysis 
buffer, pH 7.8，4 column volumes of denaturing wash buffer, pH 6.0 and 4 column 
volumes of denaturing wash buffer, pH 5.3 to eliminate any host proteins that bind non-
specifically to the resin. Elution of the target protein was achieved by applying 1 x 10 
ml denaturing elution buffer, pH 4.0 to the column. All the flowthrough, washes and 
eluates at different stages of purification were saved and analyzed by electrophoresis on 
15 % SDS-PAGE under reducing condition. Gel was stained with Coomassie brilliant 
blue. 
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2.3.2.4 Western blot analysis ofthe purified rgfPRL 
To establish that the purified protein was in fact gfPRL, Western 
immunoblotting was performed on the fractions collected during the affmity 
purification using anti-common carp polyclonal antibodies provided by Dr. Richard E. 
Peter from the University of Alberta, Canada. . 
In this analysis, the fractions were first electrically fractionated in 15 % SDS-
PAGE. Then, the SDS-PAGE gel was equilibrated in the transfer buffer for 10-15 min. 
A PVDF membrane (Immobilon pSQ, Minopore) ofthe same size ofthe gel was dipped 
in 100 % methanol for a few sec. The membrane, together with 4 pieces of 3 MM 
Whatman paper, which have also been cut into the same size of the gel, was � 
equilibrated in the transfer buffer for 10 min. After the equilibration, the blotting 
sandwich was assembled within the Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad), 
taking in order: 2 pieces of3MM paper, PVDF membrane, SDS-PAGE gel and 2 pieces 
of 3MM paper (anode — cathode). Care was taken to avoid any air bubbles trapped 
between the gel and the membrane. The proteins were blotted for 45 min at 16 V. 
In the immunoblotting process, the membrane was first placed in the blocking 
buffer and was gently shaken for 2 hr. at room temperature. The polylonal antibodies 
were prepared in a 10,000-dilution fold with the blocking buffer. The blot was then 
immersed in the antibody solution and agitated gently on an orbital shaker overnight at 
4 °C. The blot was washed with an excess amount of TTBS twice, each time for 
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15 min. Then, the blot was placed in a solution of 1:1,000 diluted goat-anti-rabbit 
alkaline phosphate-conjugated secondary antibodies (Sigma) for 45 min. at room 
temperature. After washing the blot twice with TTBS, the antibody-bound membrane 
was submerged into the freshly prepared developing solution until the colour developed. 
The reaction was stopped by rinsing the blot with a large amount of distilled water. 




2.3.2.5 Protein concentration determination of the rgfPRL 
The BCA Protein Assay Reagent Kit (Pierce) was used to determine the protein 
concentrations of the total protein expressed and the purified rgfPRL. The assay is 
based on the bicinchoninic acid (BCA) for colorimetric detection and quantitation of 
total protein (Smith et al., 1985). Aliquots ofthe purified fraction were dialyzed against 
IX TBS to remove high concentrations of guanidine hydrochloride (6 M), which would 
interfere with the assay. A set of six protein standards was,.prepared by diluting the 2 
mg/ml BSA stock standard (Pierce) in IX TBS. BCA working reagent was prepared by 
mixing 50 parts ofBCA reagent A with 1 part ofBCA reagent B. For each reaction, 0.1 
ml of each standard of sample was mixed with 2 ml working reagent. The reaction 
mixtures were incubated at 37 °C for 30 min. Absorbance was measured at 540 n m � 
against the blank. A standard curve was drawn by plotting the reading at OD540 versus 
its concentration in ^g/ml. From the standard curve, the protein concentration of the 
purified concentration and the production yield can be calculated. 
The BCA reaction profile is shown as follows: 
Protein + Cu^^ (pale green) •> Tetradentate - cV+ complex 
Cu'+ + 2 BCA ~> BCA — Cu�+ ternary complex (purple) 
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2.3.3 Protein refolding 
The purified rgfPRL was diluted with renaturing solution to give a final 
guanidine hydrochloride concentration of 4 M and a protein concentration of about 
25 ^g/ml. The renaturing solution was added drop by drop and the mixture was stirred 
continuously to ensure a fast and efficient mixing of the solution. After the dilution 
process, the mixture was left stirring at 4 °C for 48 hr. The rgfPRL was then refolded 
by stepwise removal of denaturant and NDSB-256 by dialysis: 24 hr. in 4 M, 2 M, 1 M, 
0.5 M, 0 M guanidine hydrochloride, respectively in IX TBS, 2 mM EDTA, pH 8.0 
(modified from Wemer et al.’ 1994; Levine et al., 1995; Zuhl et al., 1997; Blisnick et 
al., 1998; Vuillard etal., 1998). 
% 
Refolding of the rgfPRL was analyzed by SDS-PAGE under reducing and non-
reducing conditions. One part of denatured or refolded rgfRPL was mixed with an 
equal part of Laemmli buffer (Bio-Rad) with or without p-mercaptoethanol. The 
samples were fractionated on 15 % SDS-PAGE with Commassie brilliant blue staining. 
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2.4 Results 
2.4.1 Subcloning and DNA sequencing of the gfPRL cDNA amplified by PCR 
The protein coding sequence was amplified from the gfPRL cDNA clone P8A 
using two oligonucleotides: CCPRL-5, which contained nucleotides encoding the first 
six amino acids and to generate a BamHl site at the 5，end, and CCPRL-3, which 
contained nucleotides encoding 5 amino acids (183 一 187), a termination codon and 
creating an FcoRl site at the 3，end. After the PCR, the amplified gfPRL fragment was 
analyzed on a 1.5 % agarose gel (Fig. 2.2). The size of amplified gfPRL cDNA was 
about 600 bp. 
% 
The gfPRL cDNA was then cloned into the pUC18 vector and propagated in 
m* 
DH5a. DNA sequencing of the cloned insert was carried out using the M13/pUC 
forward and reverse primers that bound specifically to the primer binding regions 
flanking the multiple cloning site of pUC18 vector. The result (data not shown) showed 
that the sequence of the cloned fragment was the same as that of the protein coding 
region ofgfPRL clone P8A. The DNA fragment was then subcloned into the pRSETA 
vector for protein expression. 
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Fig. 2.2 Agarose gel electrophoresis of the PCR products amplified from P8A using 
two primers, CCPRL-5 and CCPRL-3. 
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2.4.2 Expression and purification of rgfPRL 
2.4.2.1 Prokaryotic expression of rgfPRL 
After transforming the ligated plasmid vector into E. coli strain 
BL21(DE3)pLysS, expression of rgfPRL was directed by the addition ofIPTG. In the 
pilot expression of rgfPRL (Fig. 2.3)，six out of ten clones produced a high level of 
recombinant protein and clone 2 was chosen for the subsequent studies. 
r 
The accumulation of rgfPRL in BL21(DE3)pLysS was determined by a time-
course study (Fig. 2.4). The expression level of the recombinant protein increased 
gradually and reached a maximum eight hours after the IPTG induction. In reducing 
SDS-PAGE, the recombinant protein had an apparent molecular weight of 25 kDa. At 
the same time，there was an observable increase of the host protein, especially after 
ovemight incubation. 
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Fig. 2.3 Pilot expression of rgfPRL in BL21(DE3)pLysS. M: low molecular weight 
marker; C: uninduced control and 1-10 stand for clones 1-10 ofinduced cells. 
Total cell lysates were prepared by centrifuging 1 ml ofcells. The pellet was 
resuspended in 100 ^1 of IX TBS. Ten ^1 ofresuspending cells was mixed 
with an equal volume of sample buffer and heated in a boiling water bath for 5 
min. After analyzing the samples on 15 % SDS-PAGE, a protein ofabout 
25 kDa was found to accumulate after the induction by IPTG. 
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Fig. 2.4 Time-course studies of rgfPRL expression in E. coli. Bacterial cells were 
grown in an orbital shaker at 37 °C. Samples were taken at time 0 - 8 hr. and 
overnight after the IPTG induction. Each lane contained the equivalent of 100 
d^ of cell culture. The samples were analyzed on 15 % SDS-PAGE under 
reducing conditions. Gel was stained with Coomassie brilliant blue. The 
expression ofrecombinant protein increased gradually and became maximized 
8 hours after the induction by IPTG. 
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2.4.2.2 Affinity purification ofrgfPRL 
In the large-scale expression, the cells collected after incubation were disrupted 
by several freeze-thaw cycles and sonication. The soluble and insoluble protein extracts 
from E. coli were analyzed on SDS-PAGE under reducing conditions (Fig. 2.5). It was 
found that the rgfPRL mainly accumulated as inclusion bodies during the expression. 
To isolate the recombinant protein under denaturing conditions, the insoluble 
I* 
fraction was first solubilized in 6 M guanidine hydrochloride before loading onto the 
Ni2+-chelating column. The column was washed and eluted with the "pH gradient" 
method. Electrophoretic analysis of collected fractions at different stages of 
purification is shown in Fig. 2.6 A. The His-tagged bound to the Ni^^-chelating resiR, 
while the majority of the host cell proteins passed through the column and could be 
found in the "flowthrough" fraction. Host cell proteins which bound non-specifically to 
the resin under the binding conditions could be washed away with the lower pH buffers 
(e.g. pH 6.0 and pH 5.3) without affecting the binding ofthe His-tagged protein. After 
removing the contaminants, the tagged protein was eluted with pH 4.0 buffer. 
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Fig. 2.5 Solubility of recombinant gfPRL. Whole proteins ofE. coli from uninduced 
(UI), induced (I) culture, supernatant (S) and isolated inclusion bodies (P) were 
boiled in the sample buffer before electrophoresis on 15 % SDS-PAGE. The 
sizes of the low molecular weight markers (M) were indicated. The rgfPRL 
aggregated mainly as inclusion bodies during the expression. 
67 
2.4.2.3 Western blot analysis ofthe purified rgfPRL 
Purified proteins were further characterized by the Westem blot analysis, using 
the rabbit anti-common carp polyclonal antibodies. Results from the immuno-detection 
(Fig. 2.6 B) supported the findings in the electrophoretic analysis. The His-tagged 
recombinant protein bound exclusively to the Ni^^-chelating resin during purification 




2.4.2.4 Protein concentration determination of rgfPRL 
After the purification, the protein concentrations of the total cellular protein, the 
、 
insoluble protein and that of the purified protein were determined and the data are 
shown in Table 2.1. The purified rgfPRL accounted for up to 9 % ofthe total protein in 
the whole cell extract and up to 80 % in the insoluble fraction of the total cellular 
protein. 
Concentration of total protein /L of culture 303 mg 
Concentration of insoluble protein /L of culture 35 mg 
Concentration of purified protein/L of culture 27.95 mg 
Percentage of purified protein over the total protein 9.22 % 
Percentage of purified protein over the insoluble protein 80 % 


















































































































































































































































































































































































































































































































































































































































































































2.4.3 Protein refolding 
Analysis of the purified gfPRL after the denaturation-renaturation process is 
shown in Fig. 2.7. In case of the purified rgfPRL before refolding, the protein 
molecules migrated as reduced monomers under both reducing and non-reducing 
conditions. After protein renaturation, rgfPRL migrated faster under non-reducing 
conditions than under the reducing conditions. Most of the proteins after the refolding 
process have their disulfide bonds regenerated. The protein existed as a more compact 
1« 
oxidized form under non-reducing condition and so its migration rate was faster than 
f^ 
that under the reducing conditions. 
、 
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Fig. 2.7 SDS-PAGE analysis of the refolded rgfPRL. The sizes of the low 
molecular weight markers (M) are indicated. Recombinant gfPRL before 
and after the refolding process are indicated as P and RP respectively. RP 
and RRP are the proteins treated with Laemmli buffer in the presence of p-
mercaptoethanol. NP and NRP are the proteins treated with Laemmli 
buffer only. The recombinant protein after the refolding process migrated 
faster under non-reducing condition than under reducing condition. 
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2.5 Discussion 
To obtain a large amount of gfPRL for further analysis, the protein coding 
region of the desired gene was inserted as a cartridge in a suitable expression vector. 
Eukaryotic hosts for recombinant protein expression are usually chosen for their ability 
to produce properly folded and biologically active molecules at reasonable yields. 
However, expression of protein in the eukaryotic cell processing system is time 
consuming. For example, it takes time to generate a stable transformed cell line and it 
requires a significant period of time to generate large quantities ofprotein. To generate 
产 
a large amount of recombinant protein in a time at low cost, convenient and efficient 
production ofrgfPRL was carried out in the bacterial expression system. 
% 
Upon the induction of IPTG, a major protein was produced. On reducing SDS-
PAGE，this protein had an apparent molecular weight of 25 kDa, which was different 
when compared to the theoretical value of21 kDa calculated from the expected amino 
acid content. In this case, gfPRL was expressed as a recombinant fusion protein with a 
leader peptide of about 4 kDa. The leader peptide included a 6 x His affinity tag and an 
enterokinase recognition site. This accounted for the appearance of higher molecular 
weight rgfPRL compared to the natural occurring one. 
pRSETA is a kind of the expression vector specially designed for expression of 
protein driven by a T7 promoter. For protein production, the vector must be 
transformed in a strain carrying a T7 RNA polymerase gene in the chromosome under 
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the control of a lac promoter, which is inducible by IPTG. However, even in the 
absence of IPTG, there is some expression of T7 RNA polymerase from the lacUV5 
promoter. This kind of promoter is referred to as "leaky" promoter because it always 
has a basal level transcription of the target gene product. 
In our studies, a high expression level of rgfPRL could be achieved eight hours 
after the IPTG induction. After the overnight incubation, level of rgfPRL expression 
showed a relative decrease. It seems that host protein expression overrides the 
recombinant protein expression. Therefore, a lengthy inciibation time was avoided and 
产 
the cells were harvested for the downstream process 8 hr after the induction. 
Overexpression ofa heterologous protein can lead to the formation of inclusion 
、 
bodies. The propensity to form inclusion bodies does not correlate with other factors, 
such as the size of the expressed polypeptide, the use of fusion constructs, the subunit 
»* “ 
structure, or the relative hydrophobicity of the recombinant protein (Kane and Hartley, 
1988). Inclusion bodies are insoluble aggregates of the recombinant protein. They are 
formed from the accumulation of folding intermediates rather than from the native or 
unfolded polypeptide. Formation of inclusion bodies when eukaryotic proteins are 
expressed in E. coli may be due to the following reasons: the presence of protein 
secretory sequence may obstruct folding, resulting in misfolded molecules; the reducing 
environment of cytoplasm may decrease the stabilizing effect of the disulfide bonds; 
and the inability of E, coli to glycosylate the protein may reduce the solubility of the 
intermediate, resulting in insoluble aggregates (Freedman, 1992). In addition to the 
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heterologous polypeptide, inclusion bodies contain host proteins such as RNA 
polymerase and outer membrane proteins, ribosome components, circular and nicked 
forms of plasmid DNA (Hartley and Kane, 1988). Some ofthese impurities may derive 
from co-precipitation upon overexpression of the foreign gene product. On top of the 
above, the inclusion body protein is misfolded and has no biological activity. 
Therefore, the inclusion bodies have to be solubilized, purified and refolded to its 
functional form in order to regain biological activity. 
Inclusion bodies are held together by noncovalent forces, mainly hydrophobic 
interactions, van der Waal's forces, hydrogen bonds and electrostatic effects (Georgiou 
and Bowden, 1991). To disrupt these kinds of noncovalent interactions, the insoluble 
bodies isolated from the total cell extract in our studies were solubilzed in 6 M of 
guanidine hydrochloride before purification on the affmity column. In general，、 
guanidine hydrochloride is preferable to urea as the presence of isocyanate in urea 
solutions can cause irreversible modifications of amino or thiol groups of the 
polypeptide (Hagel, et al., 1971). When passing through the column, protein containing 
the 6 X His affinity tag bound to the Ni^^-chelating resin with high affinity (Kd = 10"^ )^ 
at neutral pH (pH 7.8) even in the presence of 6 M guanidine hydrochloride (Hochuli et 
a/.，1988), while most of the contaminating proteins could be eliminated. Background 
contamination can arise from proteins that contain neighboring histidines, and thus has 
some affinity for the resin; proteins that associated non-specifically to the affinity-
tagged protein, and nucleic acids that bound to the tagged protein. All these 
contaminants bound to the resin with relatively low affinity and could be washed away 
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at reducing pH. Reducing the pH would cause the His residues to become protonated, 
and so dissociated from the Ni^^-chelating resin. Protein with 6 x His tag would be 
eluted around pH 4.0. 
From the purification profile of rgfPRL (Fig. 2.6)，the solubilized protein bound 
tightly to the resin and appeared only when the column was washed with the elution 
buffer (pH 4.0). The results were verified with the Westem immunoblotting using the 
rabbit anti-common carp polyclonal antibodies. Common carp shared about 97 % 
sequence homology with goldfish (Table 1.3) and so the polyclonal antibodies could 
help the detection of rgfPRL. ^From the blot, besides the 25 kDa protein, protein of 
molecular weight of about 50 kDa could also be detected. The protein must possess one 
or more than one 6 x His affinity tags so that it is only present in the pH 4.0 elution. 
Besides, it showed positive reactivity towards the polyclonal antibodies. Therefore, it 
was suggested that the protein was actually a dimeric form of rgfPRL instead of the 
»* 
contaminating host protein. 
The affinity tag that bound to the Ni^^-chelating resin during purification 
consists of a stretch of just six consecutive His residues. These extra amino acids at the 
N-terminal represent only a small portion of the recombinant protein. A wide variety of 
proteins produced under the same expression system have been examined to find 
whether the affinity tag would interfere with the structure or ftinction of the purified 
protein (Dobeli, et al., 1990; Stuber, et al.’ 1990; Janknecht, et al., 1991; Takacs and 
Gerard, 1991). The findings revealed that the 6 x His tag is non-immunogenic. It is 
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uncharged at physiological pH and will not affect the secretion, compartmentalization 
or folding of the protein to which it is attached. Based on the above reasons, there is no 
need to remove the 6 x His affinity tag from the recombinant protein after purification. 
When solubilizing the inclusion bodies in a strong denaturant such as guanidine 
hydrochloride, the recombinant proteins will be unfolded. To regain the biological 
activity of rgfRPL, the proteins have to refold to its correct structure. Refolding of 
rgfPRL was initiated by gradual dilution of the denatured protein into the refolding 
buffer, together with careful reformation of the disulfide bridges. Once the denaturant 
concentration is reduced, the protein refolds at rate equivalent to first order kinetics 
(Fig. 2.8). 
. , fast • fast , fast , slow . • 
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Fig. 2.8 Schematic representation of the kinetic competition between folding and 
formation of aggregates. U is the unfolded form of protein; Ii, I2, Iw are the 
folding intermediates; N is the native form of protein; Au, Ai, A2, A^ are the 
inactive aggregates. 
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upon in vitro protein folding, the correct pathway competes with the formation 
of inactive aggregates (Buchner and Rudolph, 1991). As illustrated in Fig. 2.8, 
aggregation may originate from non-specific interactions at the level of the unfolded 
protein, as well as from the partially structured folding intermediates. As a result of the 
competition between second (or higher)-order aggregation reactions and the first-order 
folding steps, protein precipitation occurs. Increasing concentration of unfolded 
polypeptide chains will increase the rate of aggregation, while the half-time for the 
unimolecular folding reaction remain constant. Therefore, in order to reduce 
aggregation, the denatured protein should be diluted to very low concentrations, which 
may be of the order of 10-100 ^ig/ml. 
Refolding of the denatured protein can be done in many ways such as dilution, 
dialysis and diafiltration (Wemer, et al., 1994; Levine, et al., 1995; Zuhl, et al” 1997>. 
In our studies, the denatured protein was first diluted into the renaturation solution to 
give a final guanidine hydrochloride concentration of 4 M and a protein concentration 
of about 25 ^ig/ml before the dialysis. This two-step refolding procedure allows the 
protein to flow to a relatively stable state in the presence of an intermediate denaturant 
concentration before undergoing the second step of dialysis to remove the denaturant. 
Dialysis allows the denaturant to be reduced gradually rather than by sudden change 
that occurs with dilution, and at the same time, supplies the renaturing solution to the 
denatured protein. Dialysis in this case was carried out at 4 °C. Lower temperature 
would reduce the rate of aggregation, allowing more protein molecules to fold to the 
native state. 
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When expressed in the prokaryotic system, proteins containing Cys are likely to 
have their intramolecular disulfide linkage incorrectly formed. The use of p-
mercaptoethanol together with EDTA in the renaturing solution will prevent air 
oxidation, providing the necessary reducing condition for proper refolding. 
Regeneration of the correct disulfide bonds can be achieved by maintaining a redox 
potential with low molecular weight thiol compounds. A redox pair of reduced (GSH) 
and oxidized glutathione (GSSG) creates the necessary oxidizing potential to break and 
make disulfide bonds in the folding intermediates, thereby allowing the native 
conformation to be reached. This thiol/disulfide exchange reaction increases the rate 
and yield of protein renaturation/reoxidation by reshuffling any improper disulfide 
bonds (Wetlaufer, 1984). 
When diluting the denatured protein into the renaturing solution, there is a high 
tendency for the proteins to aggregate. In an intermediate denaturant concentration 
(2-4 M guanidium hydrochloride), the proteins are extremely inclined to aggregate as 
they are not yet refolded but no longer denatured. To prevent aggregation and promote 
efficient refolding of the denatured rgfPRL, a non-detergent sulphobetaine (NDSB 256) 
(Calbiochem) was used. NDSBs are a family of zwitterionic solubilizing and 
stabilizing agents for proteins. They will not alter the pH or viscosity of the renaturing 
solution. NDSBs do not possess large hydrophobic structures, so they are highly 
soluble in water without any michelle formation and can be simply removed by dialysis. 
NDSBs behave as folding helpers for a variety of structurally very different proteins 
(Goldberg, et al” 1996; Ochem, et al., 1997; Vuillard, et al., 1998). The charge-
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screening effect and the contribution from the hydrophobic groups of NDSBs are the 
two mechanisms that may help to explain the solubilization and stabilization properties 
ofNDSBs in facilitating protein renaturation. 
Concerning the charge-screening effect, over a wide range of pH, NDSBs 
produce two opposite charges, which are divided by a carbon bridge, thus creating a 
dipole. The dipole charge interactions between NDSBs and the charges on the protein 
molecules may be able to prevent the formation of the non-specific ionic or dipole 
protein-protein interactions. .‘ 
产 
During the refolding process, non-native, intrachain or interchain hydrophobic 
interactions may form, which will lead to the formation of protein aggregates. The 
hydrophobic chains linked to the nitrogen in NDSBs probably help protein refolding by 
weakening the abortive hydrophobic interactions, which might lead to misfolding and 
fc» 
aggregation. NDSBs slow down early folding steps through competition between 
NDSB-protein interaction. As a result, NDSBs favour strong specific native-like 
interactions by preferentially preventing the weaker interactions that may lead to protein 
aggregation, thus helping the formation of native structure. 
Expression of heterologous protein in bacteria is by far the most widely used 
approach for the production of cloned gene products, both for the structure-function 
studies and for commercial purpose. It allows the production of large quantities of 
recombinant protein at low cost. Although the recombinant proteins were often 
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deposited within the host cell in the form of insoluble aggregates, isolation and 
purification of them are relatively straightforward processes. Provided that the optimal 
process parameters have been established for solubilization and in vitro protein 
refolding, the retrieval of a large amount of active recombinant protein from the 
bacterial system can be greatly enhanced and it should be followed by the receptor-
ligand binding assay or some biological functions analysis. In our studies, the receptor-
binding ability of the refolded rgfPRL was demonstrated in a radioligand binding assay, 





Chapter 3 Production of polyclonal antibodies against rgfPRL 
3.1 Introduction 
Antibodies can be raised as components of polyclonal antisera or as monoclonal 
immunoglobulins. The former involves successive immunization and bleeding of the 
chosen animals. The choice of animals is normally determined by the quantity of serum 
required and immunogenicity of the antigen in various species. The latter involves 
manipulation of immune lymphocytes or their gene •‘ components. Monoclonal 
antibodies are usually produce'd as the secretory products of cloned B lymphoblastoid 
type cell lines. They can be produced either by cell culture, bacterial fermentation or as 
ascitic fluid in animals. 
、 
The rgfPRL has been expressed and purified with the pRSETA expression 
w 
vector to provide milligram quantities of the protein. Repeated rabbit immunisations 
with the purified protein were performed in order to produce high-titre polyclonal 
antibodies. Blood was collected after each boost and polyclonal antisera were obtained. 
In order to get rid of the background normal serum proteins and to obtain reactive 
purified antibody, Immunoglobulin G (IgG) was isolated on immobilized protein A-
agarose and the titre was assessed by enzyme linked immunosorbent assay (ELISA) and 
Western blotting. The polyclonal antibodies could then be used in the purification of 




Sodium phosphate 20 mM 
NaCl 100 mM 
Adjust to pH 7.4. 
ImmunoPure® IgG purification kit (Pierce) 
Protein A AffinityPak™ cloumn .‘ 
ImmunoPure IgG binding buffer 
ImmunoPure IgG elution buffer 
Excellulose™ column 
’ 
Carbonate-bicarbonate buffer (for ELISA) 
»» 
Na2CO3 1.59g/L 
NaHCO3 2.93 g/L 
NaN3 0.2 g/L 
Adjust to pH 9.6. 
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TBST (for ELISA) 
Tris base 2.4 g/L 
NaCl 8 g/L 
NaN3 0.5 g/L 
Tween 20 0.1 %w/v 
Adjust to pH 7.4. 
Blocking buffer (for ELISA) 
5 0/0 BSA in TBST. ,‘ 
r 
Wash buffer (for ELISA) 
3 0/0 skim milk powder in TBST. 
% 
pNPP substrate solution (for ELISA) 
p-nitrophenyl phosphate lOmg/ml 
Tris buffer 0.2 M 
The solution is freshly prepared. 
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3.3 Methods 
3.3.1 Immunization of rabbits 
The rgfPRL purified under denaturing conditions was dialyzed to remove 
excessive guanidine hydrochloride before injection into the animals. The polyclonal 
antibodies against rgfPRL were raised in a rabbit with the help of the Service & 
Equipment Maintenance Team, Department ofBiochemistry, CUHK. The schedule of 
II 
antibodies production is shown in Table 3.1: 
r 
Date Nature 
18-5-1998 Priming immunization 
29-6-1998 Firstbooster 
10-7-1998 First bleed 
27-7-1998 Secondbooster 
10-8-1998 Second bleed 
25-8-1998 Third booster 
3-9-1998 Third bleed 
9-10-1998 Final booster 
19-10-1998 Final bleed 
Table 3.1 Immunization schedule of the rabbit with rgfPRL. 
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• 
In our studies, the rabbit was immunised subcutaneously to raise polyclonal 
antibodies. For the priming immunization, 0.5 ml complete Freund's adjuvant was 
added to 0.5 ml purified rgfPRL (100 i^g) in saline. The mixture was then emulsified 
manually until the emulsion became very thick and not dispersed when a drop of it was 
placed on the surface of a saline solution. Prior to injection, the skin of the rabbit's 
back was pulled away from the underlying muscle. Then, a 24-G needle was inserted 
all the way through the skin. Care was taken to avoid piercing the muscle tissue. A 
total of200jid ofemulsion was injected at five different sites to avoid severe granulomas 
in a local area. .‘ 
r 
3.3.2 Collection of the polyclonal antisera 
Six weeks after the priming immunization, the rabbit was boosted 
subcutaneously with 100 |ig rgfPRL, which had been emulsified in incomplete Freund's 
»* 
adjuvant (1:1). Further booster immunizations were administered at 4-week intervals. 
Ten to fourteen days after the booster, blood was collected from the ear artery of the 
rabbit. Serum was then isolated and stored at -20 °C or below for IgG purification and 
titer determination. 
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3.3.3 Purification of IgG from the polyclonal antisera 
Before purification, the Protein A AffinityPak™ column was equilibrated with 
ImmunoPure IgG binding buffer. The serum sample was diluted 1:1 with ImmunoPure 
IgG binding buffer prior to its application to the Protein A column so that the proper 
ionic strength and pH were maintained for optimal binding. The diluted serum was then 
applied to the column and it was allowed to flow completely into the gel. After 
washing the Protein A column with ImmunoPure IgG binding buffer, the bound IgG 
was eluted with the ImmunoPure IgG elution buffer. Elution of bound proteins was 
monitored by absorbance at 280 nm. 
For desalting of IgG preparation, the immobilized Protein A eluate was applied 
to the Excellulose™ column that had been equilibrated with phosphate-buffered saline. 
Aliquots of the equilibration buffer were loaded onto the column and fractions were 
collected. Protein concentration was quantitated by absorbance at 280 nm. The purified 
IgG was analyzed by SDS-PAGE (Section 2.3.2.2). Finally, the purified IgG was 
diluted 1:100 with the equilibration buffer and the aliquots were stored -20 °C for 
subsequent use. 
86 
3.3.4 Enzyme linked immunosorbent assay (ELISA) 
Immunoreactivity test of the polyclonal IgG with various concentrations ofrgfPRL 
The polyclonal IgG purified from the sera of two rabbits were tested with 
various concentrations of rgfPRL. Purified rgfPRL was diluted with the carbonate-
bicarbonate buffer, giving a serial protein concentrations ofO ng, 0.01 ng, 0.1 ng, 1 ng， 
10 ng, 100 ng, 200 ng and 500 ng. At the same time, purified IgG was diluted with 
TBST so that the antibody was tested in 1:500，1:1000, 1:2000，1:5000 and 1:10000 
folds ofdilution. The titre of polyclonal antibodies from the two rabbits was compared 
and the optimum dilution of the antibodies was determined for the use ofthe following 
ELISA and Western blot analysis. 
% 
One hundred i^l of rgfPRL diluted in carbonate-bicarbonate buffer were added to 
•« 
each well of the 96 well enzyme immunoassay micro-titre plate (Coming). The plate 
was incubated overnight at 4 °C in a humid chamber so that each well was coated with 
the antigen. After the incubation, the contents ofeach well were discarded. Unbound 
antigen was removed by washing with the washing buffer by filling, then inverting and 
shaking the plate. Then, the wells were filled with blocking buffer and the micro-plate 
was allowed to stand at room temperature for 2 hr. The plate was washed again and 
was replaced with different dilution folds ofpolyclonal antibodies. After incubating the 
plate for 2 hr at 37�C，the plate was washed again but this time, the wells were filled 
with 1:1000 diluted goat-anti-rabbit alkaline phosphatase-conjugated secondary 
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antibodies (Sigma). The plate was placed at 3 7 � C and it was allowed to incubate for 
another 2 hr. After washing the plates, the wells were filled with the pNPP substrate 
solution. The plate was left in the dark at 37 °C for the yellow colour development. 
Reaction was stopped by adding sodium hydroxide to each well and the plate was read 
in a Microplate Reader (Bio-Rad) at 405 nm. 
Cross-reactivity test of the polyclonal IgG 
After determining the immunoreactivity of the anti-rgfPRL polyclonal 
antibodies, the polyclonal IgG was tested against three recombinant pituitary hormones: 
rgfGH，rgfPRL and rgfSL. The hormones were diluted in carbonate-bicarbonate buffer, 
giving a serial dilution of 0 ng, 0.01 ng, 0.1 ng, 1 ng, 10 ng, 100 ng, 200 ng and 500 ng. 
The polyclonal antibodies were tested at 1:10000 fold of dilution. � 
3.3.5 Western blot analysis for cross-reactivity 
The polyclonal antibodies produced were further analyzed by Westem blot with 
the 3 recombinant pituitary hormones. The method was essentially the same as that 
mentioned in Section 2.3.2.5. Briefly, proteins were first electrophoretically 
fractionated on 15 % SDS-PAGE under reducing conditions before transfer to a PVDF 
membrane. The membrane was blocked with 5 % skim milk in TTBS (Section 2.2) for 
2 hr. at room temperature. Immunostaining was carried out using the polyclonal 
antibodies against rgfPRL at 1:10,000 dilution made with blocking buffer at 4 °C 
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overnight. After washing the blot with an excess amount ofTTBS (Section 2.2), the blot 
was incubated with 1:1,000 diluted goat-anti-rabbit alkaline phosphatase-conjugated 
secondary antibodies (Sigma). After several washes in TTBS, the blot was developed 






3.4.1 Purification of IgG from the polyclonal antisera 
After isolating serum from the immunising rabbit, the serum was diluted and 
loaded onto the Protein A column. Figure 3.1 shows the affinity chromatographic 
purification profile of IgG from 0.5 ml of rabbit serum. The fraction with the highest 
absorbance at 280 nm (Fraction 3) was applied to the Excellulose™ column for the 
purpose of desalting. “ 
产 
The bound fraction from rabbit serum was analysed on SDS-PAGE under 
reducing conditions. Two main bands corresponding to the heavy and light chains of 
immunoglobulins were observed (Fig. 3.2). � 
The purified anti-rgfPRL IgG was diluted 1:100 with phosphate-buffered saline. 
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Fig. 3.1 The affinity chromatographic purification profile ofIgG from the rabbit serum. 
Rabbit serum (0.5 ml) was diluted with 0.5 ml of ImmunoPure IgG binding 
buffer and applied to a Protein A column. Affinity chromatography was 
performed at room temperature. 
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Fig. 3.2 SDS-PAGE analysis of the eluted fraction from the Excellulose™ column. 
Lane 1 represents the low-range protein molecular weight markers (Gibco 
BRL), lane 2 is the anti-rgfPRL rabbit IgG purified from the affinity 
Protein A column. Two main bands corresponding to the heavy and light 
chains can be found. Also, other bands can be observed and they represent 




Immunoreactivity test of the polyclonal IgG with various concentrations ofrgfPRL 
Before using the purified IgG for the subsequent analysis, the titre of the 
antibodies must be checked. Fig. 3.3 shows the immunoreactivity of the antibodies at 
different dilution folds. The polyclonal antibodies showed comparatively high 
immunoreactivity towards rgfPRL even at a final dilution fold of 1:10000. 
“ 
产 
Cross-reactivity test of the polyclonal IgG 
The cross-reactivity of the polyclonal antibodies was tested against different� 
concentrations of recombinant goldfish GH, PRL and SL at a dilution of 1:10000. The 
antibodies showed high reactivity to rgfPRL but very little dr no reactivity to the rgfGH 
and rgfSL (Fig. 3.4). 
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Fig. 3.3 The immunoreactivity of different dilution fold of the polyclonal antibodies 
against different concentrations of the rgfPRL. The antibodies showed 
significant reactivity even at 1:10000 fold of dilution. The minimum 
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Fig. 3.4 Cross-reactivity test of the polyclonal antibodies. The 1:10000 fold diluted 
antibodies was tested against rgfGH, rgfPRL and rgfSL and it showed only 
very little or no cross-reactivity with rgfGH and rgfSL. 
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3.4.3 Western blot analysis for cross-reactivity 
The anti-rgfPRL polyclonal antibodies were analysed with rgfGH, rgfPRL and 
rgfSL at a dilution fold of 5000. From the blot (Fig. 3.4), the antibodies reacted with 
rgfPRL only and showed no specific binding to rgfGH and rgfSL. Also, the intensity of 
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Fig.3.5 Western blot analysis of the anti-rgfPRL polyclonal IgG against recombinant 
goldfish GH, PRL and SL. M, low-range protein molecular weight markers 
(Gibco BRL); G1, 10 ng rgfGH; G2, 50 ng rgfGH; G3, 1000 ng rgfGH; P1, 10 
ng rgfPRL; P2, 50 ng rgfiPRL; P3,1000 ng rgfPRL; S1, 10 ng rgfSL; S2, 50 ng 
rgfSL; S3, 1000 ng rgfSL. Positive signals could be detected only at the 
positions corresponding to the rgfPRL. It indicated that the antibodies had a 
• high immunoreactivity towards rgfPRL, but not rgfGH and rgfSL. Despite the 
23 kDa recombinant protein, a positive signal could also be detected at the 
position of about 45 kDa, which might represent a dimer ofthe rgfPRL. 
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3.5 Discussion 
The rgfPRL has been expressed and purified to produce large quantities of the 
hormone. The protein was then used as an antigen to induce polyclonal antibodies in 
rabbit. 
Pure immunogen is usually essential for the production of specific antibodies. 
Immunised animals may respond to contaminants disproportionately relative to their 
u 
concentration. Therefore, recombinant protein must be purified before it can be used as 
r 
an immunogen. 
Small molecules with molecular weights less than 2-3 kDa are usually not 
% 
immunogenic. Specific antibodies against low-molecular-weight molecules can be 
produced by coupling to a "carrier protein", such as bovine serum albumin or 
hemocyanin or other synthetic matrices. In this study, the recombinant protein 
produced has a molecular weight of 25 kDa and so it does not need any conjugation. 
The polyclonal antiserum contains the specific anti-rgfPRL antibody together 
with various serum proteins. In this study, the unwanted serum proteins were removed 
and polyclonal IgG were isolated. The binding properties of IgG to protein A, a cell 
wall component of certain strains of Staphylococcus aureus, make affinity 
chromatography with protein A-agarose a very simple method for preparing IgG. The 
titre ofpurified IgG was tested by various immunoassays. 
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Antiserum is the serum of the animal immunised with purified antigens. They 
are polyclonal and therefore heterogeneous with respect to the binding affmity and 
specificity. The titre or amount of specific antibody will vary from preparation to 
preparation. Therefore, the titre must be tested before it could be used for the 
following studies. A high titre of anti-rgfPRL polyclonal antibody was detected after 
the fourth injection (data not shown). Results from the ELISA revealed that the 
polyclonal antibodies showed high reactivity towards rgfPRL but not rgfGH and rgfSL 
and the antibodies could detect rgfPRL even at a dose of 10 ng. The results were 
it 
further substantiated by the Westem blot analysis. Immunoblotting of rgfGH and rgfSL 
fT 
with anti-rgfPRL polyclonal antibodies did not reveal any signal. In the Westem blot 
analysis, besides the 25 kDa recombinant protein, weaker bands could also be detected 
at a position of about 45 kDa. The presence of these bands might be due to the 
% 
dimerization of rgfRPL. 
•» 
Results from both ELISA and Westem blot analysis implied that the anti-
rgfPRL polyclonal antibodies showed high specificity towards gfPRL. The antiserum 
can be used for many purposes, e.g. in the development of a specific radioimmunoassay 
for PRL in goldfish, in the development of an affmity chromatographic method for the 
purification of native PRL from goldfish pituitaries, etc. 
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Chapter 4 Isolation of native PRL from goldfish pituitaries 
4.1 Introduction 
To study the receptor-binding ability of the refolded rgfPRL to the PRLR, a 
positive control must be available. Teleost PRL is commonly extracted under acidic 
conditions due to its generally basic nature (Andersen et al,, 1989; Dores et al” 1993). 
However, in this case, gfPRL after the acid extraction cannot separate from the other 
1» 
pituitary proteins after the gel filtration chromatography on Superdex 75. Therefore, we 
tried to extract gfPRL under alkaline conditions (modified from Cavari et al,, 1994). 
After the alkaline extraction, highly purified PRL was isolated from pituitary� 
glands of the goldfish by a two-step isolation procedure involving gel filtration column 
chromatography and anion exchange chromatography. TKe yield was about 0.4 mg/g 
wet tissue. SDS-PAGE electrophoresis revealed only one band under reducing 
conditions. The molecular weight of native gfPRL (ngfPRL) was estimated to be 21 
kDa, in agreement with the calculated molecular weight of 20,840 Da based on the 
deduced a.a. sequence of the protein coding region of gfPRL cDNA (Chan et al, 1996). 
gfPRL was analyzed with the polyclonal antibodies against rgfPRL. The result 





Ammonium bicarbonate 50 mM 
EDTA 5 mM 
PMSF 15mM 
ddH2O to 800 ml 
Adjust to pH 8.0. Bring the volume to 1 litre. Sterilize the solution by filtration 
M 
through a 0.2 i^rn disposable membrane filter. 
fT 
Equilibration solution A (for size exclusion chromatography) 
Ammonium bicarbonate 50 mM 
% 
ddH2O to 800 ml 
Adjust to pH 8.0. Bring the volume to 1 litre. Sterilize the solution by filtration 
through a 0.2 ^m disposable membrane filter. 
Equilibration solution B (for anion exchange chromatography) 
Ammonium bicarbonate 50 mM 
ddH2O to 800 ml 
Adjust to pH 7.6. Bring the volume to 1 litre. Sterilize the solution by filtration 
through a 0.2 |im disposable membrane filter. 
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Elution solution (for anion exchange chromatography) 
Ammonium bicarbonate 50 mM 
NaCl 1 M 
ddH2O to 800 ml 
Adjust to pH 7.6. Bring the volume to 1 litre. Sterilize the solution by filtration 
through a 0.2 i^m disposable membrane filter. 
50X Protease inhibitor cocktail stock solution 
it 
Complete™ Protease inhibitor cocktail tablet 1 tablet 
(Boehringer Mannheim) 




4.3.1 Alkaline extraction 
Five hundred adult goldfish ofboth sexes were sacrificed by decapitation. The 
dorsal surface of the skull was removed to allow exposure of the brain. The brain was 
taken away and the intact pituitary undemeath was immediately collected, frozen in 
liquid nitrogen and stored at - 80 °C. 
II 
/r 
A pool of 100 pituitaries ( � 0 . 5 g) was extracted in 5 ml of extraction solution. 
The pituitaries were homogenized with a Polytron homogenizer for 2 min (15 sec 
homogenization - 15 sec rest alternate cycles) in an ice bath. The homogenate was 
stirred at 4 °C for 1 hr. After centrifUgation at 25,000 x g for 30 min., the supernatant 
was recovered and the pellet was reextracted as above. Twenty microlitres of protease 
inhibitor cocktail stock solution (per ml of supernatant) was added to the combined 
supernatant. The supernatant was kept at — 80 °C until fractionation on a gel filtration 
column. 
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4.3.2 Size exclusion chromatography 
Size exclusion chromatography of the pituitary extract was performed by FPLC 
on a gel filtration column, Superdex75 (Amersham Pharmacia Biotech)) (1.6 x 60 cm, 
particle size 34 ^im). The column was first equilibrated with two column volumes of 
equilibration solution A. Two millilitres of the supematant were applied to the column 
which was then eluted with equilibration solution A at a flow rate of 0.2 ml/min. The 
eluted fractions were monitored by absorbance at 280 nm and ELISA (Section 3.3.4) 
It 
using the anti-rgfPRL polyclonal antibodies at a dilution ofl:10,000. 
4.3.3 Anion exchange chromatography 
% 
Pooled fractions containing the ngfPRL was applied to the FPLC on an anion 
exchange column, Mono Q (Amersham Pharmacia Biotech) (0.5 x 5 cm, particle size 
10 t^m) for further purification. The column was first equilibrated with 5 column 
volumes of equilibration solution B. After loading 0.5 ml of the putative gfPRL 
fraction to the column, elution was performed with a linear gradient of elution solution 
containing 1 M NaCl at a flow rate of 0.5 ml/min. The fractions were monitored by 
absorbance at 280 nm and ELISA using the anti-rgfPRL polyclonal antibodies at a 
dilution of 1:10,000. The procedure of ELISA was essentially the same as in Section 
3.3.4 except for the following step: 20 i^l instead of 100 i^l ofaliquot from each fraction 
was diluted in carbonate-bicarbonate buffer and added to each well of the 96 well 
enzyme immunoassay micro-titre plate (Coming). Ten microlitres of protease inhibitor 
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cocktail stock solution (per 0.5 ml of collected fraction) was added to the fraction 
containing native gfPRL. The fraction was kept at - 80 °C until further analysis. At the 
end of each stage of the purification process, aliquots were saved and were analyzed by 
SDS-PAGE (Section 2.3.2.2) and Westem blotting using the anti-rgfPRL polyclonal 





4.4.1 Size exclusion chromatography 
Result of size exclusion chromatography of an alkaline extract of goldfish 
pituitaries on a gel filtration column, Superdex75 is shown in Fig. 4.1. Several peaks of 
absorbance were detected at A280 (data expressed as the unit of mAU in the figure). The 
collected fractions were analyzed by ELISA using anti-rgfPRL polyclonal antibodies 
II 
and the result is shown in Fig. 4.2. Peak 1 represented the direct "flowthrough" from , 
the column. Peak 2，as examined by our colleague, contained a large amount of gfGH. 
The major immunoreactive components against anti-rgfPRL polyclonal antibodies were 
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Fig. 4.1 Size exclusion chromatography of the goldfish pituitary extract on 
Superdex75. An alkaline extract of 100 adult male and female goldfish 
pituitaries were fractionated by size exclusion chromatography on a Superdex 
75 column, column size: 1.6 x 60 cm; particle size: 34 ^m. The column was 
equilibrated and eluted in 50 mM ammonium bicarbonate (pH 8.0) at a flow 
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Fig. 4.2 Analysis of the collected fractions from Superdex 75 by ELISA using the 
anti-rgfPRL polyclonal antibodies. Fractions 32-35 showed high 
‘immunoreactivity towards the anti-rgfPRL polyclonal antibodies. The 
antibodies were used at a dilution of 1:10000. 
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4.4.2 Anion exchange chromatography 
The pooled fractions were further purified on an anion exchange column, Mono 
Q (Fig. 4.3). Proteins were fractionated along with the linear salt gradient elution and 
were monitored by absorption at 280 nm (data shown as the unit ofmAU in the figure). 
The collected fractions were analyzed again by ELISA using the anti-rgfPRL polyclonal 
antibodies and the result is shown in Fig. 4.4. Aliquot from fraction 20 showed high 
reactivity towards the anti-rgfPRL polyclonal antibodies, suggesting that this fraction 
II 
contained a high concentration of purified ngfPRL and the result was further confirmed 
产 
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Fig. 4.3 Anion exchange chromatography of pooled fractions 32-35 on a Mono Q 
column. Pooled fractions from Superdex 75 were separated on Mono Q 
(column size: 0.5 x 5 cm; particle size: 10 |im). Proteins were eluted with a 
linear gradient of 1 M NaCl in 50 mM ammonium bicarbonate, pH 7.6 at a 
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Fig. 4.4 Analysis of the collected fractions from Mono Q by ELISA using anti-rgfPRL 
‘polyc lonal antibodies. Fraction 20 showed high immunoreactivity towards 
anti-rgfPRL polyclonal antibodies. The antibodies were used at a dilution of 
1:10000. 
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4.4.3 SDS-PAGE analysis and immuno-detection of the purified protein 
SDS-PAGE analysis and immuno-detection of the purified protein is shown in 
Fig. 4.5. SDS-PAGE (Fig. 4.5A) of the pooled fraction (fractions 32-35) after size 
exclusion chromatography on Superdex 75 (Lane 2) revealed two Coomassie blue-
stained protein bands. After anion exchange chromatography, gfPRL was isolated as a 
single band. The single band in Lane 3 and the corresponding Commassie blue-stained 
bands in Lane 1 and 2 had identical electrophoretic mobility with an estimated 
it 
molecular weight of about 21 l ^ a . Only these protein bands reacted with the specific 
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Fig. 4.5 SDS-PAGE analysis (Panel A) and immuno-detection (Panel B) ofthe purified 
ngfPRL. The sizes of the low molecular weight markers (M) are indicated. 
Lane 1 was the goldfish pituitary extract. Lane 2 was the pooled fraction from 
the size exclusion column, Superdex 75. Lane 3 represented fraction 17 
collected after anion exchange chromatography. SDS-PAGE analysis of 
aliquots from different stages of purification showed that after the size 
exclusion chromatography, two bands could be observed. After the anion 
exchange chromatography, gfPRL was obtained as a single band and the 
purified protein was estimated to have a molecular weight of about 21 kDa. 
The identity of the protein was confirmed in the Westem blotting using anti-
rgfPRL polyclonal antibodies at a dilution of 1:10000. 
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4.5 Discussion 
Isolation of teleost PRL was first described in 1977 from tilapia pituitaries 
(Farmer et al., 1977). Current studies on the purification of teleost PRL reported that 
the hormone was commonly extracted under the acidic condition (Kawauchi et aL, 
1983; Prunet and Houdebine, 1984; Anderson et al., 1989) due to its generally basic 
nature. In case of gfPRL, when pituitaries were extracted in acid acetone and 
fractionated in acidic buffer (buffer of pH 4.6-6.3)，gfPRL together with other pituitary 
II 
proteins passed straight through the column and it resulted in no separation of variants 
(data not shown). This might be due to the partial oxidation and aggregation ofproteins 
under the acidic conditions. When the goldfish pituitaries were extracted in alkaline 
conditions (pH 8.0)，separation was greatly improved. gfPRL shared only a minor 
portion ofthe pituitary proteins. The yield of the purification was only 0.4 mg/g ofwet 
tissue (calculation not shown). "* 
The PRLs purified to date have been found to have an apparent molecular 
weight of21-23 kDa (Kawauchi et al., 1983; Prunet and Houdebine, 1984; Miyajima et 
al.，1988; Anderson et al” 1989; Suzuki et al., 1991). The molecular weight ofgfPRL 
in SDS-PAGE under reducing conditions was estimated to be 21 kDa, which was in 
agreement with the molecular weight of other fish PRLs and the calculated value 
(20,840 Da) based on the cDNA sequence. The purified protein could be used as a 
positive control to study the receptor-binding activity of the refolded rgfPRL to the 
PRLR. 
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Chapter 5 Receptor binding assays 
5.1 Introduction 
After protein renaturation, the differences in the migration patterns of rgfPRL 
under reducing and non-reducing conditions indicated that disulfide bond formation had 
indeed taken place during the renaturation steps. However, it did not show whether the 
recombinant protein has been correctly folded or not.. To address this issue, a 
competitive binding assay of ngfPRL and rgfPRL was carried out to compare their 
specific receptor binding abilities. 
Currently, several binding studies have confirmed the presence ofteleosts PRLR� 
in the osmoregulatory surfaces such as gill, liver and kidney (Dauder et al., 1990; 
Swennen et al., 1991) and receptor binding was higher in freshwater fish than in 
seawater fish. In our studies, gill homogenate from goldfish was prepared for the 
radioreceptor binding assay. 
Regarding the radioisotope, iodine-125 C^H) was used in our receptor binding 
study. Native gfPRL was iodinated by the iodogen method (Salacinski et al, 1981). 
During the iodination reaction, the ^ 1 was oxidized by a mild oxidizing agent, iodogen, 
to produce iodine (I2), which reacted with water to produce the iodinium species. This 
intum reacted with Tyr in the ngfPRL, exchanging iodine for hydrogen. The iodinated 
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ligands had high specific activities, which allowed accurate detection even at low 
binding levels. 
In the competitive radioreceptor binding assay, rgfPRL competed with labelled 
ngfPRL in vitro for the PRLR on the gill homogenate. The result obtained suggested 
that the recombinant protein has been correctly refolded in the renaturation process and 






10X Protease inhibitors stock solution 
Aprotinin 20 ^ig/ml 
Benzamidine 150 ^g/ml 
EDTA lOmM 
Leupeptin 20 ^g/ml 
Pepstatin 1,0 ^ ig/ml 
PMSF 产 lOmM 
Homogenization buffer 
HEPES buffer, pH 7.4 50 mM � 
Sucrose 0.25 M 
»* 
1 OX protease inhibitor stock solution 1X 
in 1 litre ofddH2O. 
Resuspension buffer 
HEPES buffer, pH 7.4 50 mM 
1 OX protease inhibitor stock solution 1X 
in 1 litre ofddH2O. 
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IX TBS 
Tris-HCl 20 mM 
NaCl 0.8 % w/v 
Adjust to pH 7.4. 
Incubation buffer 
Tris-HCl 200 mM 




Bovine serum albumin 0.1 % w/v 
Dissolve in lXTBS. 
% 
Precipitation buffer “ 
Bovine serum albumin 0.001 % w/v 
Dissolve in IX TBS. 
Assay buffer 
Maleate buffer, pH 6.2 50 mM 
Bovine serum albumin 0.4 % w/v 
Bacitracin 0.2 % w/v 
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5.3 Methods 
5.3.1 Gill membrane preparation 
Gill filaments obtained from goldfish were rinsed with a large amount of ice-
cooled saline several times to get rid of excessive blood. The wet weight of the gill 
filaments was recorded. The tissues were cut into smaller pieces and then transferred 
into the homogenization buffer in which the wet weight of the tissues was about 20 % 
i> 
(w/v) ofthe homogenization buffer. The tissues were homogenized with a tissue tearor 
for 5 min (30 sec homogenization - 30 sec rest alternate cycles) in an ice bath. The 
homogenate was centrifuged at 600 x g for 10 min. The supernatant was centrifuged 
again at 10,000 x g for 20 min. The supernatant was collected and its salt concentration-
was adjusted to 0.1 M NaCl and 0.2 mM MgCl2. The supernatant was centrifuged at 
40,000 X g for 30 min. The supernatant was discarded. The pellet was resuspended and 
washed in the resuspension buffer with a Teflon pestle homogenizer. The suspension 
was centrifuged again at 40,000 x g for 30 min. The final pellet was resuspended in the 
resuspension buffer in a ratio of 1 g of wet tissue per ml ofresuspension buffer. The gill 
membrane aliquots were stored at - 70 °C. 
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5.3.2 Radioactive labelling of the primary ligand 
Native gfPRL was iodinated by the iodogen method (Salacinski et al., 1981), 
with some modifications. The reaction was conducted in a radiation safety approved 
fume hood. For the preparation of iodogen-coated tubes, iodogen (Pierce) was first 
dissolved in dichloromethane (CH2Cl2) at a concentration of 0.04 mg/ml. A 50-^il 
aliquot of iodogen solution was pipetted into a 1.5 ml polypropylene microftige tube. 
The tube was blown-dried with nitrogen gas until the solvent was completely 
evaporated. The iodogen-coated tubes were wrapped with tinfoil and stored with 
desiccant a t - 2 0 °C. 
The iodination reaction proceeded optimally near neutral pH, pH 7.0 - 7.5. For� 
the iodination, 10 i^l of ngfPRL (2 |ig), 35 i^l ofthe incubation buffer (pH 7.4) and 5 ^1 
125 ^ 
of Na I (0.5 mCi) (Amersham Pharmacia Biotech) were placed into the iodogen-
coated tube. The solution was mixed by gentle finger-flicking. The iodination reaction 
was allowed to proceed for 15 min at room temperature. Iodinated ngfPRL was 
separated from free iodine by subjecting the reaction mixture to the desalting column 
PD-10 (Amersham Pharmacia Biotech), which had been equilibrated with 20 ml of 
elution buffer. Subsequently, the column was eluted with 5 ml ofelution buffer and 10 
0.5-ml fractions were collected. The elution profile of radioactive labelling was 
obtained by taking 10 i^l of each fraction for gamma counting using the Kontron® 
gammatic counter with 80 % counting efficiency. The amount of radioactivity was 
120 
presented as counts per minute (cpm). The radioligand was stored at 4 °C until further 
analysis. 
5.3.3 Determination of the percentage of ^^ 1^ incorporation and specific 
radioactivity of the radioligand 
Ten microlitres of the labelled protein was precipitated with 1 ml of 
precipitation buffer and 1 ml of ice-cooled 20 % trichloroacetic acid (TCA). The 
t> 
mixture was incubated at 4 � C for 15 min. Iodide not bound to the protein remained in 
solution while the iodinated protein was precipitated. The mixture was then centrifuged 
at 4200 X g for 45 min at 4 °C. The amount of radioactivity ofthe supernatant and the 
pellet from each fraction were taken for gamma counting. The amount of radioactivity 
in the supernatant represented free iodine together with other iodinated peptides while 
that of the pellet represented iodinated ngfPRL. 
Assumption of one hundred percent of protein in the labelling process was 
iodinated and recovered was not typical. Therefore, the percentage of radioisotope 
incorporation and the specific radioactivity of the tracer were estimated before the 
receptor binding assay and they could be determined as follows: 
• 
Percentage of radioisotope incorporation 
=• cpm of pellet 
cpm of pellet + cpm of supernatant 乂 � 
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specific radioactivity of tracer 
= T o t a l incorporated radioactivity (^iCi / ^g) 
Total amount of protein 
To calculate the total incorporated radioactivity, the cpm of the pellet was 
converted to disintegrations per minute (dpm) based on a counting efficiency of 80 % 
for the gammatic counter. The dpm was then converted to t^Ci (1 ^Ci = 2.22 x 10^ 
dpm). “ 
r 
5.3.4 Membrane protein dependence assay 
、 
The number of PRLR varies with different kinds of tissue of different species. 
Before carrying out the receptor binding assay, the amount of gill membrane used 
should be determined. Membrane protein dependence assay was performed in 5-ml 
polypropylene tubes containing 2 i^l ^^^I-labelled ngfPRL (20,0000 cpm), 20 mM 
CaCl2，in the absence or presence of 2 i^g ofunlabelled ngfPRL, increasing amounts of 
membrane protein (10’ 20, 50, 100, 200, 300, 400 and 500 ^ig) in a final volume of0.5 
ml assay buffer, in duplicates, for each set of assay. The content of each tube was 
mixed gently and the tubes were incubated at room temperature for 20 hr. The binding 
was stopped by adding 2 ml of ice-cooled assay buffer to the tubes. Subsequently, the 
samples were centrifuged at 42,00 x g for 30 min. at 4 °C. The supematant was 
discarded and radioactivity in the pellet was taken for the gamma counting. The total 
bound (TB) radioactivity was obtained in the absence of unlabelled ngfPRL. Non-
122 
specific binding (NSB) was determined in the presence of excess (2 i^g) unlabelled 
hormone. Specific binding (SB) could be calculated by subtracting NSB from TB. The 
amount of membrane protein to be used in the receptor binding assay could be 
determined by plotting a graph of percentage of binding against the amount of 
membrane protein added in each assay. The percentages of specific and non-specific 
binding were calculated as follows: 
Percentage ofbinding (specific) = SB x lOO� / 
Total added radioactivity 
产 
Percentage ofbinding (non-specific) = NSB xlOOo/o 
Total added radioactivity 
’ 
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5.3.5 Receptor binding study using rgfPRL 
The experimental conditions were essentially the same as the membrane protein 
dependence assay except for the contents in the assay tubes. In this case, the total 
bound (TB) radioactivity referred to the tubes with labelled ngfPRL only. Non-specific 
binding 0^SB) was determined in the presence ofexcess (2 |ag) unlabelled ngfPRL. For 
the binding studies, 2 ^1 ^l-labelled ngfPRL (20,0000 cpm), 20 mM CaCl2, 100 i^g of 
membrane protein and in the presence of different concentrations ofunlabelled ngfPRL 
or rgfPRL (0.2, 2，20，200，2000 ng) were added to the iodogen-coated tubes in a fmal 
volume of0.5 ml assay buffer, in triplicates. The binding of ngfPRL and rgfPRL to the 
PRL binding sites on the gill membrane could be observed as the displacement curves 
of labelled ngfPRL. The percentage of specific binding was calculated as follows: � 
»» 
Percentage of specific binding 
= B - N S B _ X 100% 
TB - NSB 
where B represented the counting (in cpm) of the pellet in the presence of different 
amounts of unlabelled ngfPRL or rgfPRL. 
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5.4 Results 
5.4.1 Radioactive labeling of the primary ligand 
After the iodination, the iodinated ngfPRL was separated from free iodine using 
the size exclusion column (PD-10 column). The ^^ 1^ radioactive labelling profile of 
ngfPRL is shown in Fig. 5.1. The � - ! labelled hormone began to be eluted in fraction 
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Fig. 5.1 Separation of ^I-ngfPRL from free iodine on a PD-10 column. The 
iodination mixture was applied onto the PD-10 column and eluted with 5 
ml elution buffer. Ten 0.5-ml fractions were collected and 10 \i\ of each 
faction was counted in a gamma counter. 
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( 
5.4.2 Determination of the percentage of ^^ 1^ incorporation and specific 
radioactivity ofthe radioligand 
The percentage of ^^ 1^ incorporation of each collected tube was determined and 
it was found that ⑵！ labelled ngfPRL in tubes 4-7 had more than 90 % of ⑵工 
incorporation (Fig. 5.2). Radioligands in tubes 5-7 were used for the receptor binding 
assay as they had higher counts and percentage of ⑵！ incorporation. The calculated 
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Fig.5.2 Percentage of ^ 1 incorporation in each fraction of Fig. 5.1. '^ ^I-labelled 
ngfl>RL was mainly present in fractions 4-7. These fractions were found to 
‘have more than 90 % of ^ 1 incorporation. 
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5.4.3 Membrane protein dependence assay 
Specific binding of ⑵！ labelled ngfPRL increased with the amount of gill 
membrane added in the receptor binding assay (Fig. 5.3). Specific binding increased 
linearly with the amount of membrane protein added up to 100 i^g. The percentage of 
specific binding was about 10 %. At the same time, the percentage of non-specific 
binding also increased, but at a comparatively low level when compared with that of 
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Fig. 5.3 Membrane protein dependence study. Increasing amounts of gill membrane 
were incubated with a fixed amount oflabelled ngfPRL. Receptor binding was 
expressed as a percentage of added radioactivity. Total binding (TB) was 
‘obtained with labelled ngfPRL only. Non-specific binding Q^SB) was 
determined in the presence of excess (2 i^g) unlabelled hormone. Specific 
binding (SB) could be calculated by subtracting NSB from TB. 
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5.4.4 Receptor binding study using rgfPRL 
Competitive binding assay was carried out with a given amount of ^^ 1^ labelled 
ngfPRL and increasing amounts of unlabelled ngfPRL and rgfPRL. In the binding 
assay, total binding was obtained with labelled ngfPRL only. Non-specific binding 
(NSB) was determined in the presence of excess (2 i^g) unlabelled ngfPRL. Fig. 5.4 
shows the curves for displacement of ⑵！ labelled ngfPRL with different amounts of 
unlabelled ngfPRL and rgfPRL. The EC50 of ngfPRL for goldfish gill membrane was 
1» 
about 10 ng/500 i^l while that of the rgfPRL was about 42 ng/500 i^l. The displacement 
curve of rgfPRL appeared to be parallel to that of ngfPRL. This indicates that rgfPRL, 
like its native counterpart, is also able to displace labelled ngfPRL from its receptor on 
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Fig. 5.4 Displacement of 旧1 labelled ngfPRL from gill membrane with different 
amounts ofunlabelled ngfPRL and rgfPRL. The ECjo ofngfPRL for goldfish 
‘gill membrane was about 10 ng/500 i^l while that of the rgfPRL was about 
42 ngy^ 500 ^1. 
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5.5 Discussion 
There are three alternative methods for iodinating PRL: chloramine T method 
(Greenwood et al., 1963), iodogen method (Salacinski et al., 1981) and lactoperoxidase 
method (Hirano et al., 1985). The reaction mechanisms of these three methods during 
the iodination reaction are essentially the same. In this study, iodogen method was 
chosen for the iodination of ngfRPL. Iodogen is a mild oxidizing reagent and is suitable 
for proteins that are easily damaged by oxidation. The reaction proceeds more slowly 
1« 
than the other two methods. The reaction time is longer and very reproducible. 
Besides, this method is much simpler than the other two methods in which there is no 
need to prepare the "stopping" regent in order to terminate the iodination reaction 
(chloramine T and lactoperoxidase methods), or to swell the enzymobeads� 
(lactoperoxidase method) before the labelling reaction. For the iodogen method, 
iodogen is evaporated onto the wall of 1.5 ml polypropylene microfuge tube before 
addition of protein and radioisotope. Reaction is terminated until removal of the 
mixture from the tube. 
Following incubation of the gill membrane, '^^I-labelled ngfPRL and the 
unlabelled hormones, the bound radioligand have to be separated from the free ligand. 
There are various kinds of separation methods. Different kinds of receptor preparation 
require different separation techniques. Particulate receptor binding assay using crude 
gill membrane is suitable for separation by centrifugation or filtration. For the receptor 
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binding assay using the solubilized receptor, dialysis, gel filtration or by adsorption / 
precipitation would be a choice. 
Membrane receptor binding data is usually reported as specific binding. In the 
mathematical analysis of binding, total binding does not reflect the real radioreceptor 
binding. Specific binding is defined as the difference between total binding and non-
specific binding, carried out under identical conditions in the presence of excess, 
saturating displacing ligand. Non-specific binding may arise from the binding of 
It 
radioligand to other tissue components such as enzyme binding sites and ion uptake 
sites), binding to the inner surface of the polypropylene tube, or the free radioligand that 
has not been washed away (Bennett and Yamamura, 1985). 
% 
Goldfish gill membrane PRLR binding assays were performed under the pH of 
6.2 instead of performing at physiological pH (pH 7.4). At pH 7.4，although the non-
specific binding remained essentially the same as that obtained at pH 6.2, the total 
binding decreased sharply (data not shown). It seemed that a slightly acidic condition is 
preferred for the goldfish gill membrane PRLR binding assays. 
In the membrane protein dependence assay, provided that the radioligand is a 
limiting factor, the percentage of specific binding reaches a maximum of about 20 % 
when 300 i^g of gill membrane are added in the binding assay. In the subsequent assay, 
100 i^g ofmembrane preparation were used in which the percentage of specific binding 
was about 10 %. In this concentration of membrane protein, the radioligand had to 
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compete with each other for hormone binding sites on the membrane. Therefore, in the 
competitive binding assay, decrease in the specific binding was the result of 
displacement of the radioligand from its receptors. 
In the competitive binding assay, the EC50 of ngfPRL for goldfish gill 
membrane was about 10 ng/500 i^l while that of the rgfPRL was about 42 ng/500 i^l. 
The data implied that only 25 % of the recombinant protein have been correctly 
refolded. Results from the receptor binding study using rgfPRL showed a parallel 
relationship between the displacement curves ofngfPRL and rgfPRL. This implies that 
the recombinant protein, after the refolding steps, had regained its structural properties 
as its natural counterpart and was capable of competing with ngfPRL for receptors on 
the gill membranes. � 
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Chapter 6 General discussion and conclusion 
General discussion 
The expression of proteins in bacteria {E. coli) is by far the most commonly 
used approach for the production of cloned gene products. There are several reasons 
why bacteria are so useful for protein expression. First ofall, E. coli are much easier to 
grow than eukaryotic cells. Second and most important, a large amount ofrecombinant 
protein can be produced at one time and the cost of production is relatively cheap. 
Overexpression ofrecombinant protein in E. coli can result in the formation ofinclusion 
bodies in cell cytoplasm or periplasm. Inclusion bodies are insoluble aggregates of the 
misfolded recombinant protein. It is likely that the disulfide bonds of the recombinant� 
proteins are incorrectly formed and so they have no biological activities. Thus, there is 
a need to refold the inclusion body to its native structure in order to regain the 
biological activity. 
In this case, the protein coding region ofgfPRL cDNA, P8A, was subcloned into 
the pRSETA expression vector. The pRSETA/P8A was then transformed and 
propagated in the E. coli strain BL21(DE3)pLysS. Expressed rgfPRL was identified as 
the main protein (~ 80 %) in the insoluble fraction ofthe total cellular protein. Isolation 
ofrgfPRL from the cell wall debris in the inclusion bodies required the solubilization of 
insoluble aggregates by strong denaturants such as guanidine hydrochloride. 
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Protein purified under denaturing condition is misfolded and generally lacks 
biological activities. To regain the native conformation, the purified protein required an 
additional downstream process: in vitro refolding. Refolding processes for successful 
renaturation of protein vary from protein to protein and they generally involve gradual 
dilution of the denaturants. However, it would lead to the production of very diluted 
refolded protein. Sometimes, protein refolding on gel filtration may help to solve such 
problem but protein loss during the run may be unpredictable. In our studies, in 
addition to the traditional gradual dilution and dialysis techniques, a mild solubilizing 
agent, the non-detergent sulphobetaines (NDSB-256) was used during the refolding 
steps. This solubilizing agent effectively prevents the formation of precipitates during 
the dilution and dialysis steps and thus promotes high yield ofcorrectly folded protein. 
、 
The purified rgfPRL was used to raise a polyclonal antibodies in a rabbit. The 
polyclonal antibodies were able to differentiate PRL from growth hormone and 
somatolactin in both ELISA and Westem blot analysis, and so it was used to detect the 
presence ofgfPRL throughout the purification from the goldfish pituitaries in this study. 
The antiserum can also be used for many purposes. The polyclonal antibodies can be 
used for quantitative detection of the expression of PRL in goldfish 9r other fish 
species. By means of homologous radioimmunoasaay, the level of PRL in the plasma 
of goldfish or other fish species can be determined, and so the seasonal and 
developmental changes of plasma PRL level can be elucidated. Besides, the polyclonal 
antibodies can be used to develop an affinity chromatographic method for one step 
purification of native PRL from fish pituitaries. 
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Highly purified ngfPRL was isolated from goldfish pituitaries by a two-step 
isolation procedure involving gel filtration and anion exchange chromatography. 
Previous studies on the purification of teleost PRL reported that the hormone was 
commonly extracted under acidic conditions (Kawauchi et al” 1983; Prunet and 
Houdebine, 1984; Anderson et al, 1989) due to its generally basic nature. The isolation 
procedure of gfPRL in this study demonstrated that teleost PRL can also be extracted 
under alkaline conditions. Besides serving as a positive control in our receptor binding 
studies, the highly purified ngfRPL can be used to study the biochemical properties of 
teleost PRL such as the three-dimensional structure and the protein domain (s) that 
is/are responsible for the receptor binding. 
The receptor binding assay for rgfPRL performed on gill membrane is a n � 
important aspect in assessing the receptor binding ability of the refolded rgfPRL. When 
tested on the gill membrane, the rgfPRL exhibited high a potency in competing with 
i25i-iabelled ngfPRL for the gfPRL receptor. The parallel relationship obtained between 
the displacement curves of ngfPRL and rgfPRL (Fig. 5.4) implied that the recombinant 
hormone recognized the same hormone receptors on the gill membrane, as the natural 
counterpart, in a dose dependent manner. Therefore, it can be concluded that the 
rgfPRL has the same activity in this bioassay as the naturally occurring gfPRL. 
Although many studies have been done to investigate the biochemical features 
of tish PRL, the three-dimensional structure and the structure-function relationship in 
receptor binding are still unknown. With large amounts of active recombinant protein 
138 
in hand, it is now possible to study the relative contributions of the protein domains of 
the hormone molecule towards the receptor binding and biological activity of the 
hormone. This would facilitate dissection of the structure-function relationship of fish 
PRL. In the long run, such information regarding structure-function relationship is 
fundamental to the logical design ofbiosynthetic hormones or transgenes with a view to 




IPTG-inducible T7 RNA polymerase-driven system provides a simple way to 
obtain a large amount of rgfPRL in E. coli. About 28 mg ofrgfPRL was produced in 1 
L ofbacterial culture. The purified gfPRL accounted for up to 9 % ofthe total protein i n � 
the whole cell extract and up to 80 % in the insoluble fraction of the total cellular 
protein. When analyzed on SDS-PAGE under reducing conditions, the molecular 
weight ofthe recombinant protein was estimated to be 25 kDa. Gradual removal ofthe 
denaturants by dilution and dialysis, together with the use of the non-detergent 
sulphobetaines O^DSB-256) increased the yield ofcorrectly folded protein. 
The polyclonal antibodies against rgfPRL showed high reactivity towards 
rgfPRL but not rgfGH or rgfSL in ELISA and Westem blot analysis. The antibodies 
could detect rgfPRL even at a dose of 10 ng. 
After alkaline extraction, the ngfPRL was isolated from the goldfish pituitary 
extract by gel filtration and anion exchange chromatography. When analyzed on SDS_ 
139 
PAGE under reducing conditions, the purified protein appeared as a single band and its 
molecular weight was estimated to be 21 kDa. 
The refolded rgfPRL recognized the same hormone receptors on the gill 
membrane and was capable of displacing the labelled ngfPRL from its receptor on gill 
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